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Abstract 
Metalloproteins play important roles in biology, as they account for 
nearly half of all proteins in nature, spanning a remarkable functional range, 
from fundamental chemical reactions, such as electron transfer, dioxygen 
transport and activation, hydrolysis, group transfer and rearrangements, to 
signaling processes governing gene regulation and expression.
1,2
  
The same metal cofactor is able to serve different roles depending on 
the protein architecture, as the physical and chemical properties of a selected 
metal depends on the protein environment.  In fact, a plethora of mixed 
interactions occur between the metal cofactor and the protein matrix, fine-
tuning the intrinsic reactivity of the metal.
3
  
A prominent illustration of how the metal center reactivity is 
modulated by the surrounding protein environment is provided by heme-
proteins, that are a family of important macromolecules ubiquitous in 
biological systems characterized by a common prosthetic group (the “heme” 
group), which perform a wide range of biological functions, and participate 
in a wide range of essential biological processes: myoglobin and hemoglobin 
reversibly bind dioxygen, cytochromes support electron-transfer processes, 
cytochrome P450 activates dioxygen to form water and an oxygen atom, 
which is inserted into a substrate.
4
 
A powerful approach to deeply understand the factors that specify the 
functions of natural heme-proteins is the engineering of peptide-based 
models that mimic protein active sites in simplified scaffolds. To date, 
several artificial heme-proteins have been engineered, providing provide 
further insights on -activity relationships.
5
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In this respect, the Artificial Metalloenzyme group, where this project 
has been carried out, developed a class of artificial heme-mimetics, named 
Mimochromes. These models are composed of two peptide chains covalently 
linked to the heme group via amide bonds between the porphyrin 
propionates and the lysine side-chains.
6
 
 
Early compounds of this class were made up of two identical nona-
peptide chains, each containing a histidine residue which acts as axial ligand 
to the heme central ion (iron or cobalt), in a low-spin bis-His-ligated state. 
The peptide chains were in an -helical conformation in both the apo and 
metal containing species, and these molecules adopt a stable and well 
defined conformation, being able of supporting electron transfer processes.  
More recently, many efforts have been made in order to design new 
compounds (Mimochrome VI and its analogues) that bind iron in five-
coordinate complexes, with a vacant coordination site available for 
catalyzing oxidation reactions. This efforts lead to the development of new  
models that have peroxidase-like activity, being able of catalyzing organic 
substrate (such as ABTS) oxidation, by the use of hydrogen peroxide. In 
particular, one of this analogues, showed catalytic performance approaching 
that of HRP.
7
 
One main drawback of these new molecules relies in the lack of 
detailed information of their three-dimensional structures. Attempts to solve 
the structure on the fully diamagnetic Co(III) complex were unsuccessful. In 
fact, analysis of the Nuclear Magnetic Resonance (NMR) spectrum of 
Co(III)-Mimochrome VI revealed the presence of different species in 
solution. 
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7 
 
This PhD project was aimed at overcoming the presence of multiple 
species in solution, developing heme-mimetics that couple high activity with 
a well defined structure. In this respect, two different strategies have been 
undertaken: 
 
 incorporation of non-coded amino acid with -helix stabilizing 
effect; 
 
 elongation of the peptide chains, that allows the introduction of a 
large number of intra-chain and inter-chain interactions. 
 
The first strategy led to the development of a new Mimochrome VI 
analogue, named Mimochrome VI-2U1L. The second strategy resulted in the 
design of the Mimochrome VII molecule. 
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For both compounds, a detalied NMR analysis was performed, and 
information about the three- dimensional structure of the Co(III)- complexes 
was achieved.  
For Co(III)-Mimochrome VI-2U1L, four different species were present 
in soultion. The four species were purified by RP-HPLC and separately 
analyzed by NMR. In particular, for two of these species (peak a and peak 
b), the solution structures of the tetradecapeptide-porphyrin moiety was 
solved. The tetradecapeptide adpots in solution the expected helical 
conformation in the Asp
1
 -Lys
9
segment, while distortion is observed at the 
C-terminal region (intended to fold in extended conformation). 
Regarding the decapeptide chain, severe overlaps make difficult the 
structural characterization. In order to solve the oserved ambiguity of 
assignment, further experiments are required. Indeed, the information 
obtained from the Co(III)-Mimochrome VI-2U1L molecule, will be very 
useful in order to analyze the structure-function relationship on 
Mimochorme VI and its analogues. 
 
Regarding the Mimochrome VII molecule, two species were presnt in 
solution. The structure of the more abundant specie was determined and 
good agreement was observed between the designed model and the 
determined NMR structure, apart from the first 4 residues at the N-terminal 
region. The two peptide chains adopt right-handed helical conformation from 
Pro
6 
to Leu
16
,
 
while a less regular conformation is observed in the N-terminal 
region. As designed, the global structure is stabilized by the presence of 
interactions between hydrophobic side chains and deuteroporphyrin ring. 
These information will be used to re-design new molecules 
characterized by asymmetrical metal binding site, in order to introduce new 
Abstract 
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functionalities. Preliminary, in this PhD thesis the design of a penta-
coordinated model, Mimochrome VII asym, was carried out. This new model 
is characterized by a distal cavity that contains an arginine residue, 
mimicking Arg
38
 of Horseradish Peroxidase (HRP), and a non-coordinating 
His residue to mimic His
42
 of HRP. Its characterization is actually under 
course. 
 
Finally, part of this work was devoted to the structural characterization 
of active sites in paramagnetic iron(III) mimochrome complexes. In 
particular, the orientation of the histdine axial ligands in the Fe(III) 
complexes of mimochrome IV was determined, by taking advantage of a 
methodology previously used for natural ferriheme-proteins. 
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1. Chapter 1: design of artificial metallo-proteins 
1.1.  Metallo-proteins 
Many life-sustaining process, like nitrogen fixation, photosynthesis 
and respiration, involve proteins containing metal-binding centers, that are 
generally referred as metallo-proteins. They account for nearly half of all 
proteins in nature, and play important roles in biology, spanning a 
remarkable functional range, from fundamental chemical reactions, such as 
electron transfer, dioxygen transport and activation, hydrolysis, group 
transfer and rearrangements, to signaling processes governing gene 
regulation and expression.
4,5,8,9
 Despite their low abundance in terms of 
mass, numerous metal ion, including various ‘trace’ elements, are an 
absolute requirement for all life forms. Na
+
, K
+
, Mg
2+,
 Ca
2+
, Zn
2+,
 Mn
2+
, 
Ni
2+
, Cu
+/2+
, Fe
2+/3+
, and Co
2+/3+ 
are frequently found in biological 
organisms.
8,10-19
Also, recent advances in mass spectrometry, X-ray 
scattering/absorption, and proteomics have demonstrated that even elements 
such as uranium, arsenic, and lead are involved in biological processes (Fig. 
1). Interestingly, some metals can be toxic at elevated levels, but are 
essential in trace amounts.
20
 
While a small amount of metals are present in the human body both as 
free cations (such as Na
+
 and K
+
) or minerals (such as hydroxyapatite 
crystals), many others are incorporated into biomolecules as cofactors.
21
 The 
physical and chemical properties of a selected metal depends on the protein 
environment, where a plethora of mixed interactions that occur between the 
metal cofactor and the protein matrix mutually affects the properties of each 
other, thus enhancing, diversifying, or tuning their individual functions.
22-25 
Therefore, often the same metal cofactor is able to serve different roles 
depending on the protein architecture.  
Introduction: chapter 1 
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Fig. 1 Periodic table emphasizing biologically relevant elements and bio-metals. The highly 
abundant building blocks of nature are shown in green, metals described to be associated 
with metalloproteins are shown in orange and non-metal trace elements in blue. Catalytic 
metals present in active sites of enzymes are marked with a red star. Dotted boarders 
highlight metals incorporated into microbial biomass into a recent studies of Cvetkovic et al. 
Reprinted from Current Opinion in Structural Biology, Vol. 23, Yannone et al., Metals in 
biology: defining metalloproteomes, pages 89-95.,20Copyright (2012), with permission from 
Elsevier.  
 
Most metal-binding sites include only a small number of coordinating 
amino acids, in a specific spatial arrangement. In most cases, the 
coordinating amino acid are histidine (His), cysteine (Cys), aspartic (Asp), 
and glutamic acid (Glu). Less commonly, tyrosine (Tyr), methionine (Met), 
serine (Ser), lysine (Lys), glutamine (Gln), asparagine (Asn), threonine 
(Thr), and glycine (Gly) are also coordinated to metal ion (Fig. 2). With the 
exception of glycine, which coordinates a metal ion through the backbone 
carbonyl oxygen, the other amino acids participate in coordination almost 
exclusively through their side chains containing sulfur, oxygen or nitrogen as 
donor atoms.
11,3
 Metal ion preferences for a certain amino acid side chain 
follow the general rules of coordination chemistry and often can be 
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interpreted using the theory of hard and soft acids and bases (HSAB 
theory).
26
 Furthermore, metal ion can also be coordinated by exogenous non-
amino acid cofactors, such as organic macrocyclic ligands, like porphyrin, 
corrin, and chlorin groups or inorganic entities (e.g., oxide, hydroxide, 
water).
27,28
  
 
Fig. 2 Amino acids containing donor atom( s) in their side chain. 
The ligand binding mode is a important factor in modulation of the 
protein affinity/selectivity for a given metal, and plays an important role in 
tuning the metal reactivity. Therefore, it is a key aspect in determining 
metallo-protein functions. However, metallo-protein functions are also 
subtly related to the specific arrangement of non-coordinating amino acid in 
Introduction: chapter 1 
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the proximity of the active site. Hydrogen bonds and ion pairs formation, 
charge distribution and specific ligand affinity strictly modulate the 
properties of the metal-binding site. Consequently, understanding the 
minimal requirements for function in metallo-protein is a complex task. 
Several approaches have been used to shed light on structure-function 
relations in metalloproteins:  
 
 Bioinformatics, that aims at identifying metallo-proteins in diverse 
genomes from primary sequence data. However, this approach is 
generally limited to the analysis of closely homologous of well-
characterized proteins. While various metal-binding motifs have been 
identified, and some are useful in classify probable metallo-proteins 
from primary sequence, in most cases computational approaches fail 
to predict specific protein-bound metals.
20
 
 
 Structural biology, that aims to determine the three-dimensional 
structures of proteins. Structure databases are the main sources of 
information on the characteristics of metalloproteins at an atomic 
level. The Protein Data Bank (PDB), a worldwide archive of atomic 
coordinates and other information describing proteins and other 
important biological macromolecules, include about 30000 metallo-
proteins structure, obtained by X-ray crystallography, Nuclear 
Magnetic Resonance (NMR) spectroscopy, and cryo-electron 
microscopy (Fig. 3).
29,30
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Fig. 3 Metals in the Protein Data Bank, January 2011. 
 Mass spectrometry of metallo-proteins that is a powerful tool for 
analyzing many structural and behavioral aspects of metallo-proteins 
in great detail. Several MS techniques have been developed for 
determining the locations of metal-binding centers, metal oxidation 
states and reaction intermediates of metallo-proteins.
31-33
As example, 
inductively coupled plasma mass spectrometry (ICP-MS) allows 
rapid and sensitive quantification of metals from complex biological 
samples, ESI-MS enables the determination of protein–metal ion 
binding stoichiometry in solution, and metallo-protein higher order 
structure in the case of multi-subunit proteins.
20,21 
 
These and other approaches led to a deep understanding of the roles of 
metals in biological processes.
19
 Traditionally, metallo-proteins are ranked 
with respect to their function in three classes (Fig. 4): 
 transport or storage proteins; 
 signal transduction proteins; 
 metallo-enzymes.  
Introduction: chapter 1 
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The first class include metal storage proteins, electron carriers, and 
oxygen binding proteins. The second class involves metal sensing and 
switching proteins. The third class involves metallo-proteins able to catalyze 
a wide range of chemical reactions. Analysis of enzyme mechanisms, 
restricted to enzymes with known structure, has shown that metallo-enzymes 
represent about 40% of all enzymes.
34,35
 
 
Fig. 4 Classification of metallo-proteins according to their functions.35  
In recent years, the growing number of metallo-proteins of known 
three-dimensional structure have prompted numerous studies that attempt to 
classify metallo-proteins from a structural point of view according to metal- 
binding site properties, such as the presence of a certain metal, the 
coordination number and the amino-acid residues involved in metal 
coordination. All these studies provide new insights on protein folding, 
structure, and function of metallo-proteins, and are a valuable tool for the 
identification of metal-binding sites in proteins of unknown structure. Also, 
Introduction: chapter 1 
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they laid the groundwork for the design of artificial proteins that reproduce 
metal coordination environments of native proteins. 
 
1.2.  Heme-proteins 
Heme-proteins are a class of biologically important macromolecules 
ubiquitous in biological systems and characterized by a common prosthetic 
group, the “heme” group: a tetrapyrrole macrocycle, called porphyrin, that 
bind an iron ion. Despite sharing the same  cofactor, heme proteins perform 
a large array of biological functions, providing a clear illustration of how the 
metal center reactivity is modulated by the surrounding protein environment. 
In fact, depending on the heme environment, these proteins catalyze 
numerous chemical reactions, and participate in a wide range of essential 
biological processes: myoglobin and hemoglobin reversibly bind dioxygen, 
cytochromes support electron-transfer processes, cytochrome P450 activates 
dioxygen to form water and an oxygen atom, which is inserted into a 
substrate. Peroxidases use hydrogen peroxide to oxidize several organic 
substrates (Fig. 5).
4
 
 
Fig. 5 Crystal structure of: a) cyochrome -P450cam (PDB code 5CP4);36 b) horse hearth 
cytochrome c (PDB code 1AKK);37 c) horseradish peroxidase (HRP) (PDB code 1ATJ);38 d) 
deoxyhemoglobin (PDB code 1HGA).39 
 
Due to this high functional versatility, heme-proteins have been the 
focus of numerous studies, aimed at describing the structural and functional 
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properties of heme binding sites. Myoglobin was the first protein whose 
structure was determined, using X-ray crystallography, by Sir John Cowdery 
Kendrew, an English biochemist and crystallographer, in 1958.
40
 Two years 
later, Max Perutz published the structure of hemoglobin.
41
 These discoveries 
earned to the two scientists the Nobel Prize in Chemistry 1962, that was 
awarded jointly to Max Ferdinand Perutz and John Cowdery Kendrew "for 
their studies of the structures of globular proteins”.42 Since then, high-
resolution X-ray crystallographic data, as well NMR three-dimensional 
structures, become available for an increasing number of heme-proteins, 
together with a large number of functional characterizations, and today the 
protein data bank contains over 2300 structures of proteins containing one or 
more heme groups.
43
  
 
1.3. The heme prosthetic group 
The basic structure of natural heme proteins is a tetrapyrrole 
macrocycle called porphyrin, with a skeleton as shown in Fig. 6 that consists 
of four pyrrole-like five-membered units, which are linked by four methine 
bridges (meso positions). It has 11 double bonds, which means 22 π 
electrons, and 18 of these electron are involved in a delocalization pathway, 
forming an aromatic system that obeys Huckel's rule of aromaticity (4n + 2 π 
electrons, n = 4) and is shown by X ray crystallography to be planar. The 
porphyrin free base has two inner pyrrole protons that can be replaced by a 
metal ion (Fe, Co, Ni, Cu, Zn), forming a metallo-porphyrin complex, with 
the four pyrrole nitrogen atoms acting as metal ligands.  
Introduction: chapter 1 
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Fig. 6 The tetrapyrrole macrocycle. 
The pyrrole nitrogen forms a relatively rigid hole for a cation, close to 
but smaller than the diameter of high-spin Fe
2+
or Fe
3+
. The porphyrin ligand 
is a good four-centered σ donor, and it is also an effective π acceptor. The 
energy level diagram of the iron porphyrin also indicate that the high-spin 
iron in the ring, whether in the Fe
2+
 or Fe
3+
 state, is quite close in energy to 
the low-spin state, and indeed to intermediate spin state. This spin state 
equilibrium balance is one of the delicate controls, which the porphyrin ring, 
together with the protein matrix, exhibits over the metal ion.
3
 
The porphyrin macrocycle exists in various forms, differing in the 
pyrrolic substituents. The most common metalloporphyrin in biologically 
system is the heme b, an iron(II) protoporphyrin IX that noncovalently binds 
to proteins, found in b-type cytochromes, globins, cytochromes P-450 and 
hemesensor proteins. Another very common form is the heme c, a modified 
heme b in which the porphyrin macrocycle vinyl groups forms thioether 
bonds with two cysteine residues, forming a classical Cys-Xaa-Xaa-Cys-His 
(CXXCH) motif, found in cytochromes c and cytochrome f. Other heme 
types, obtained by modifications of b-type heme that can be found in heme-
proteins are a- and d-type hemes contained, for example, in the terminal 
oxidases (heme a) and catalase (heme d).
5,44
 The structures of these 
commonly occurring hemes are illustrated in Fig. 7. 
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In addition to the pyrrole nitrogen atoms, the metal ion is usually 
capable of binding one or two supplementary ligands, called axial ligands, 
that severely influence the spectroscopic, electrochemical and functional 
properties.
45
  Several amino acids are able to serve as axial ligands to heme 
iron.  
In some heme-proteins, the protein provides only one axial ligand, 
whereas the opposite side is open for the binding of small molecules (as 
example O2 in globins) or organic substrates (cytochrome P450, peroxidases, 
catalases).  
 
Fig. 7 Chemical structures of commonly occurring natural hemes a, b, c, and d. Reprinted 
with permission from Reedy and Gibney, Chem. Rev., 2004, 104, 617-649. Copyright 
(2004) American Chemical Society. 
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1.4. Heme binding to proteins 
In heme-proteins, the heme group is linked to the protein matrix by a 
plethora of different interactions: 
 coordination bond between the heme iron and one or two amino acids 
that act as axial ligands to the metal ion; 
 hydrophobic interactions between non-polar amino acid and the 
porphyrin macrocycle; 
 polar interactions between the propionic groups and polar side-
chains; 
 covalent bonds (in c-type heme), between the vinyl groups of the 
porphyrin macrocycle and cysteine residue side-chains. 
Furthermore, an intricate set of different interactions also contribute to 
imprinting the heme properties. Hydrophobic, ion pairing, and hydrogen 
bonding interactions control several features of the heme environment, such 
as the local dielectric constant, the heme exposure, and the orientation of the 
ligands. Variations in the mode of heme binding, in the number, type, and 
donor properties of the heme axial ligands, and in non-binding interactions 
between the heme and the protein matrix, result in different heme 
environments in proteins with different functions in biology. 
The characteristics of the primary coordination sphere, like metal 
coordination geometry, number, type, and donor properties of the axial 
ligands, play important roles in modulating the properties of heme proteins, 
such as redox potentials, electronic structure, spin states, electron-transfer 
rates, and catalytic properties. Several amino acids are known to serve as 
axial or proximal ligands to heme proteins.
43  
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Table 1. Analysis of axial ligands for heme group on a data set of 34 
nonhomologous heme proteins.  Data from ref. 43. 
Axial ligands for heme group 
His 61 
Met 8 
Cys 6 
Tyr 3 
Pro 1 
N-terminal amino 1 
Vacant/water 18 
Changes on oxidation/reduction 2 
 
The primary coordination sphere of the iron in heme proteins of known 
structure is dominated by histidine, that ligates heme iron via the Nε, also if 
there is only a single example of Nδ-bound histidine (His
102
 of Nitrosomonas 
europea cyt c554).
46
 In particular, the most frequently observed coordination 
number and ligation motif is five-coordinate mono-histidine, found as 
example in globin and peroxidases. In these proteins, the matrix provides 
only one axial ligand, histidine, whereas the opposite side is open for binding  
of exogenous molecules. The second most common coordination motif is 
six-coordinate bis-histidine, that is found in electron carriers proteins, and 
appear one-third as often as mono-histidine. Methionine and cysteine are 
also common axial ligands that coordinate the heme. In particular, a common 
ligation motif for six-coordinate heme proteins is histidine with methionine, 
as exemplified by cyt c.
47
 Bis-methionine coordination is also observed 
(bacterioferritin).
48
 Conversely, cysteine thiolate ligation is observed in five-
coordinate heme proteins, such as cytochromes P-450 and nitric oxide 
synthase.
49,50 
Furthermore, other amino-acid ligands are rarely found in six-
coordinated heme-proteins in combination with histidine, like the side-chain 
amine of lysine (cyt c nitrite reductase)
51 
the asparagine amide donor (ferric 
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SHP, Sphaeroides heme protein)
52
, the charged donors tyrosine phenoxide 
(HasA)
53
 and glutamate carboxylate (hemoglobin Milwaukee).
54
 Finally, the 
neutral N-terminal amine donor has also been found coordinated to heme 
iron in few structures (Tyr
1
 of cyt f and Pro
2
 of ferric CooA).
55,56
 
As well as the number and type of axial ligands, the coordination 
geometry play an important role on imprinting heme properties, the 
orientation of the axial ligands, with respect to the porphyrin plane, has been 
suggested to be one of the key factor in determining the heme features. This 
hypothesis originated from the evidence that, even within a common set of 
axial ligands and heme substituents, the physicochemical properties of heme 
proteins vary widely. In particular, it has been demonstrated that different 
histidine conformations can shift the redox potential of heme proteins,
46
 and 
that the spectroscopic, electronic, and magnetic properties of ferriheme 
model complexes can depend on the orientation of axially coordinated planar 
ligands.
57
 
While the axial ligands to heme iron establish the basic coordination 
chemistry, the interactions of amino acids beyond the primary coordination 
sphere (hydrophobic, ion pairing, and hydrogen bonding interaction) controls 
several features of the heme environment, such as the local dielectric 
constant, the heme exposure, and the ligand orientation, allowing it to 
perform a variety of biochemical functions. Further, the protein directs long-
range interactions and regulates the accessibility of solvent and substrates 
into the active site, thus allowing to selectively discriminate between 
different ligands and/or substrates. These factors all contribute to the 
functional versatility of the heme. In the following sections, the focus is 
pointed on two heme-protein classes: peroxidase, belonging to the mono-
histidine type and cytochromes belonging to the bis-histidine. A detailed 
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24 
 
discussion of the main factors that characterize the active site of these 
proteins is given, in order to develop new artificial heme binding proteins, 
that reproduce their heme environment.  
 
1.5.  Peroxidases 
Peroxidases are ubiquitous enzymes that catalyze the oxidation of a 
wide range of organic and inorganic substrates, such as phenols, aromatic 
amine, thioanisoles and iodide, using hydrogen peroxide.  
They are crucial for the regulation of reactive oxygen species levels 
and for the promotion of several substrates oxidation, also play major roles 
during defence and development processes, and are among the first enzymes 
to have been discovered, with references dating back to the 19
th
 century, 
describing peroxidase activity in biological system. In 1855, Schönbein 
observed the oxidation of some organic compounds, such as guaiacol, by 
hydrogen peroxide (H2O2), catalyze by “substances” present in plants and 
animals. In 1898 Linosseir used for the first time the name “peroxidase”, 
describing an enzyme isolated from pus.
58
 Since then, peroxidases are one of 
the most extensively studied groups of enzymes, and several heme 
containing peroxidases have been isolated, sequenced, and structurally 
characterized.  
To date, almost 10000 heme peroxidase have been annotated and 
classified in the peroxidase database (PeroxiBase, 
http://peroxibase.isb-sib.ch).
59
 Of these, more than 8000 belong to the “plant 
peroxidase” superfamily, which contains monomeric proteins from both 
prokaryotic and eukaryotic origin with a non-covalently bound heme. The 
plant peroxidases are further classified in three classes: class I that contains 
intracellular prokaryotic peroxidases, class II, that contains extracellular 
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fungal peroxidases, and class III that contains secretory plant peroxidases. 
The remaining heme peroxidase, are usually formed by association of 
different peptide chain. In particular, animal peroxidase are usually dimeric 
(with a covalently attached heme group), while catalase are tetrameric 
enzymes (that catalyze the dismutation of H2O2).  
Even if the structures of several peroxidases have been determined, the 
majority of the information on the structure–activity relationship have been 
obtained from the analysis of yeast cytochrome c peroxidase (CCP, 
belonging to class I of plant peroxidases) and of Horseradish (Armoracia 
rusticana) peroxidase (HRP, belonging to class III of plant peroxidases) (Fig. 
8).58, 60,61 
 
Fig. 8 crystal structure of HRP ( pdb code 1ATJ)38 and CCP ( pdb code1ZBY).62 
In the resting state, peroxidase contains an iron ion in the oxidation 
state +3, that is five coordinated to the four pyrrole nitrogens of the heme 
and to a nitrogen atom of an axial histidine, the proximal histidine (with the 
exception of chloroperoxidase which contains a thiolate ligand),
63
 while the 
sixth coordination position is free. The catalytic process occurs through 
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several steps (Fig. 9). The first step is the heterolytic cleavage of the oxygen-
oxygen bond of H2O2, followed by the release of a water molecule and 
concomitant two-electron oxidation of the protein, with the incorporation of 
one of the oxygen atom of H2O2 in an intermediate, compound I, that 
contains an oxyferryl (Fe(IV)=O) center and an organic cation radical which 
can be located either on the heme or on a protein residue, depending on the 
enzyme.  
 
Fig. 9 Peroxidase catalytic cycle showing the enzyme intermediates, compunds I and II. 
Compound I is able to oxidize a wide range of reducing substrates by a 
mechanism involving two single electron-transfers. First, it oxidizes one 
substrate molecule( s) to give a substrate radical and Compound II, in which 
the organic cation radical is discharged, while oxy-ferryl( FeIV=O) is still 
present (single electron transfer mechanism). Subsequently, compound II is 
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reduced by a second substrate molecule to the resting iron(III) state.
64,65
 On 
the proximal site, the Nδ of the proximal histidine forms strong hydrogen bond 
with an aspartate side chain (Asp
247
 in Hrp, Asp
235
 in CCP) (Fig. 10) shows 
details of the proximal and distal site of HRP). This determine an increase in 
the basicity of the coordinating histidine, thus stabilizing the ferriheme form 
in the protein resting state (push effect). The binding of H2O2 occurs in the 
distal heme pocket, which is characterized by two highly conserved residues 
in all plant peroxidase: the distal histidine and the distal arginine, that are 
involved in peroxide activation and in the formation of compound I, being 
implied in the acid-base catalytic cleavage of the O-O bond (pull effect). The 
distal histidine is thought to promote the formation of Compound I, by acting 
as a general acid-base catalyst that deprotonates H2O2 facilitating the 
formation of a ferric peroxide (Fe-OOH) complex, and subsequently 
transfers the proton to the distal oxygen 
of the ferric peroxide complex, in the 
dioxygen bond cleavage step. 
 The conserved distal arginine 
(Arg
38
 in HRP, Arg
48
 in CCP) is involved 
in the charge stabilization, (mediated by 
its positively charged guanidinium group) 
of the developing OH- leaving group of 
hydrogen peroxide. Further, once the O–
O bond is cleaved, the distal arginine 
contributes to stabilize the oxoferryl specie via hydrogen bond formation. 
The important role of these highly conserved residues has been 
demonstated by site-directed mutagenesis, since their replacement causes a 
drastic reduction of the rate of compound I formation.
 61,66-68  
Fig. 10 Heme binding site of of 
HRP 
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1.6. Cytochromes 
Cytochromes are cellular heme-containing protein whose principal 
function is electron transport. A cytochrome is defined as an heme-protein 
whose function involves transfer of reducing equivalents associated with a 
reversible change in oxidation state of the prosthetic group. Formally, this 
redox change involves a single-electron, reversible equilibrium between the 
Fe(II) and Fe(III) states of the central iron atom.  
These molecules were initially described in 1885 by C.A. MacMunn as 
respiratory pigments isolated in tissues and organs of invertebrate and 
vertebrate animals, and subsequently identified as heme containing proteins 
in 1925 by David Keilin, that introduced the name “cytocrhome” and their 
current classification, based on the characteristic of their visible-light 
absorption spectra.
69,70
 In fact, cytochromes have distinctive visible-light 
absorption spectra, and are classified depending on the position of their 
lowest energy absorption band in the reduced state, as cytochromes a (~605 
nm), b (~565 nm), and c (550 nm). Within each class, early cytochromes are 
numbered consecutively, e.g. cyt c, cyt c1, and cyt c2, with more recent 
examples designated by their reduced state alpha-band maximum, e.g. cyt 
c559. An exception is cytochromes P450, which is named on the basis of the 
wavelength of the most intense absorption band (Soret band) of the carbon 
monoxide complex of the reduced form. Various amino acids are known to 
serve as axial ligands in cytochromes, also if bis-His and His-Met 
coordination (found as example in cyt b5 and cyt c554 (Fig. 11) and cyt c, 
respectively) are the most common coordination states. Other coordination 
states, such as bis-Met and His-Lys, have also been found. Interesting, 
ligation from the terminal α-amino group of a peptide bond has also been 
observed in cyt f.
55
 Because they does not have a free coordination position 
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on the heme iron, bis-His and His-Met cytochromes are unable to activate 
exogenous molecules, such as oxygen and peroxide. Instead, they act as 
electron transfer component in many essential biological process, like 
respiration (cyt b, cytochrome c3),
71-73
 photosynthesis (cyt b6),
74
 
desaturation of fatty acids (cyt b5),
75
 nitrification pathway.
46
 In these 
cytochromes, the iron ion is in the low-spin configuration in both the 
oxidation states.  
 
 
Fig. 11 Cytochrome C554. 
Furthermore, the iron redox potential is finely modulated by the local 
protein environment surrounding the heme group. Overall, the redox 
potentials of all known cytochromes span a range of almost 800 mV, that 
corresponds, in thermodynamic terms, at about 17 kcal/mol in free energy. 
Certainly, this variation is in part due to differences in the heme- iron 
first coordination shell, as well as to modification of the peripheral 
substituents on the porphyrin (in various heme forms, such as a, b, and c), 
that cause a shift of about 150 mV.
76
 Clearly, there are additional factors that 
modulate the redox potential of the heme iron. In particular, the level of 
exposure to solvent, the heme binding mode, the charge distribution in the 
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heme environment, the orientation of the axial ligands. As an example, a 
large number of negatively charged residues around the heme favor a high 
oxidation state for the iron, while the progressive change from a negative 
charge distribution in cytochromes b to a positive one in cytochromes c, 
determines a gradual increase in the Fe(III)/Fe(II) redox potential. The 
efficient control of the reduction potential of the heme group is of crucial 
importance in electron transfer proteins, as in the biological electron transfer 
chains, the midpoint redox potential of each component dictates the direction 
of favorable transport between the individual constituents. 
 For this reasons, intense effort has been put into both experimental 
and theoretical analysis aimed at clarify the factors that determine the 
reduction potential of these metallo-proteins. However, due to the intricate 
set of factors that contributes to determine the redox potential, these studies 
often failed to identify a clear correlation between the reduction potential 
and any specified structural parameter (like heme solvent accessibility, 
number of protein-heme hydrogen bonds, nonbonded contacts).
43
 Besides 
that, some correlations can be observed limiting the analysis to very closely 
related heme proteins, for example between the heme reduction potential and 
the solvent accessibility of the heme group.  
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1.7. Artificial metallo-proteins 
Metallo-proteins are specially attractive targets for protein engineering, 
as protein design is an effective approach for mimicking metal coordination 
environments, and develop new systems that reproduce active site structures 
within a peptide scaffold.
77-81
 These systems can be very useful in 
elucidating structural features that may remain hidden in site-directed 
mutagenesis studies, as the ability to reproduce desired active sites in a 
designed system is a true test of proper knowledge of protein folding and 
functions.
1
 As design requires the incorporation of all the structural features 
needed to attain a function, the designed compounds should be of sufficient 
size and chemical diversity to allow the construction of functional sites. At 
the same time, they should be simple enough to avoid much of the ambiguity 
of interpretation associated with large proteins. Furthermore, reduced 
dimension respect to the native proteins, make these artificial metallo-
proteins easier for practical applications, which spans from biocatalysis and 
biosensor technology, to degradation of pollutants or biomass, and drug or 
food processing.
82
 
However, metallo-protein design has proven to be more challenging 
than the design of nonmetallo-proteins, since it requires a properly folded 
protein scaffold containing the correct number and type of ligands with the 
appropriate geometry to bind and activate the metal for chemical catalysis. 
On the other hand, most metal-binding sites are highly chromatic and display 
typical magnetic properties, allowing easier characterization by means of 
metal-based spectroscopic techniques rather than X-ray crystallography or 
nuclear magnetic resonance (NMR).
83,1
 Since the first reports of artificial 
metallo-proteins appeared over 30 years ago, important progress has been 
made in reproducing many native metal sites, and several examples of 
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functional metallo-proteins equipped with useful electronic or optoelectronic 
properties, high enzymatic activities or new functions have been recently 
developed (Fig. 12).
 77, 84,85 
 
 
Fig 12. NMR structure of a de novo designed four-helical bundle di-iron protein 
with phenol oxidase activity. 
Such compounds, equipped with high stability and great efficiency can 
be very useful as cheaper, more stable, and environmentally friendly novel 
chemical catalysts. Although some metal binding compounds have been 
designed through combinatorial and evolution methods (as example, there 
has been an attempt at creating new metallo-antibodies by affinity selection 
from a combinatorial library), most novel metal binding sites constructed in 
proteins have been designed using some form of rational, structure-based 
design.
86
  
The rational design of metal binding protein can be divided into two 
stages: the design of the overall scaffold and the design of active sites.
87
 
However, the two design step are closely linked: the construction of metal 
binding sites requires the integration of scaffold and active site design, as 
amino acids should be placed in the appropriate geometry to form the metal 
ion coordination shell, while also maintaining steric compatibility with the 
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rest of the protein fold. Furthermore, in order to optimize metal-binding sites 
for function, active site charge neutrality, electrostatics and metal–ligand 
bond strain should also be considered.
88,89
 As a result, the rational 
engineering of metallo-proteins is an iterative process of design, synthesis 
and rigorous characterization, until the desired properties are obtained. 
Because of the complexity of protein folding, where a large number of 
molecular interactions contributes to stabilization of the three dimensional 
structure and to the fine-tuning of the properties of metal cofactor, several 
redesign cycle are usually required, and new compounds are often obtained 
only through considerable trial and error. Despite this, three main structure-
based design methods proved to be specially appealing for the engineering of 
novel metal binding sites into proteins: 
 design or re-design of new metal-binding sites into native 
scaffolds;
90,91
 
 minimalist approach, that focus on determination of the structural 
features necessary to confer the structure and function of the enzyme, 
and involves the construction of “minimalist” sequences that are 
simpler than their natural counterparts but, nevertheless, retain 
sufficient complexity for folding and function; 
92
 
 de novo design, that involves the construction of a protein, intended to fold 
into a precisely defined 3-dimensional structure, with a sequence that is not 
directly related to that of any natural protein.93-99 
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1.8. Artificial heme-proteins 
The interest in engineering artificial heme-proteins as model 
complexes for natural proteins take advantage of great availability of 
structural data, as well as on potential application of heme-protein models. 
Also, the design of heme-protein synthetic analogues provides a mechanism 
by which to separate each factor that contribute to metal reactivity 
modulation in native heme-proteins, revealing key aspects on structure-
function relationships. Indeed, great attention has been focused on the design 
of artificial heme binding proteins, and several artificial heme-proteins have 
been engineered, providing key insight on metal proprieties modulation by 
the protein matrix. The time-honored synthetic analogue approach to heme-
proteins starts from the development of small metalloorganic complexes 
based on natural and synthetic metalloporphyrins with exogenous axial 
ligands, as catalysts for a wide range of industrial applications.
5
 This 
approach focused on elucidating the effects of metal ion coordination on the 
spectroscopy, electrochemistry, and chemical reactivity of the heme group in 
the absence of the influence of the protein matrix. This traditional approach 
has further evolved in the development of more sophisticated molecules, that 
include small peptides as axial ligands, and are better models of native 
heme-proteins.
5
 
As example, Benson et al. developed a class of artificial heme 
mimetics, named PSM, that are made up by two identical peptides covalently 
linked to iron(III) mesoporphyrin IX via amide formation between the heme 
propionyl groups and the amine of lysine side chains (Fig. 13). The peptide 
chains bear an histidine that acts as axial ligand to the heme iron, to form a 
bis-His complex.
100
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The peptide sequence was also designed such that coordination of the 
imidazole side chain of the histidine residue in each peptide to the heme 
metal would lead to helix induction. These models were extensively 
characterized, by means of CD, UV-vis and NMR. The spectroscopic 
characterization confirmed bis-His ligated state of the heme and significant 
helical content, that increased upon addition of alcohol co-solvents.
101,102
 
 
 
Fig.13 Reprinted with permission from Benson et al., J. Am. Chem. Soc., 1995. Copyright 
(1995) American Chemical Society. 
More recently, the engineering of novel metallo-proteins is also 
progressing from purely structural to more functional designs, and new 
heme-proteins models with improved properties such as higher stability, 
greater efficiency, and specific functions are emerging.
103,104
 As example, 
Koder et al. engineered an artificial oxygen transport protein, as a model of 
globin.
105
 This model was completely de novo designed, beginning with a 
simple sequence composed by only three amino-acid (E,K,L), that assemble 
to form a four-helix-bundle motif. Then, two leucine residues at internal 
position were replaced with histidine, in order to anchor the heme cofactor 
through bis-histidines coordination. Afterwards, the sequence was adjusted 
to improve structural resolution and to facilitate O2 binding. In particular, 
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water was excluded from the heme binding site by re-packing the protein 
interior and by changing the loop such that helical interface mobility was 
reduced, in order to avoid heme oxidation. The final model, shows O2 
affinities and exchange timescales that match natural globin with distal 
histidine. On the contrary, the binding of CO is weaker compared to that of 
natural globins, with the consequence that O2 binds to this model tighter than 
CO (Fig. 14).  
 
Fig. 14 Design of an artificial oxygen transport protein. Reprinted by permission from 
Macmillan Publishers Ltd, Nature, from Koder et al ref. 72.,  copyright 2009. 
 
Many efforts have also been devoted to developing artificial heme 
compounds with peroxidase like activity, and some heme-protein models 
able of performing peroxidase activity with increase efficiency have 
appeared in literature. Microperoxidase (MPs) (Fig. 15), are a class of heme 
containing products derived from cyt c proteolysis, that retain the proximal 
histidine of the parent cytochrome as a ligand to the heme iron, and are 
characterized by mono-histidine-ligated state of the heme iron.
106-111
 These 
molecules, have been very well characterized  from different research 
groups, that obtain an impressive amount of information regarding their 
coordination properties, their secondary structure, and their aggregation 
process.  
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However, the structural characterization of MPs from a three 
dimensional point of view is made hard by their flexibility and oligomeric 
propensity. Also, the analysis is complicated by the solution speciation of the 
MPs in aqueous buffers. In fact, the spectroscopic titration as a function of 
pH  indicated that there are several pKa observable  in the MP8 and MP11 
electronic spectrum, with more than one species existing in solution in the 
pH range 2-7.  
 
Fig. 15 Schematic representation of microperoxidase 8, depicted as six-coordinated aqua 
complex; the sequence of MP8. Reprinted with permission from Heme-Peptide Models for 
Hemoproteins. 1. Solution Chemistry of N-Acetylmicroperoxidase-8, Munro et al., Inorg. 
Chem, 35, 3752-3767. Copyright (1996) American Chemical Society. 
 
An example of small artificial heme models equipped with peroxidase 
activity was provided in 1997 by Hecht et co-worker, that used the binary 
patterning approach in the design of semi-random libraries of peptides, and 
verified their ability to bound heme and to function as peroxidases. In the 
binary patterning approach, the patterning of polar and nonpolar amino acids 
is specified explicitly, but the exact identities of the side chains is varied 
extensively. Thus, a binary pattern designed to fold into a specific structure 
is compatible with many different amino acid sequences. 30 different binary 
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code sequences were synthesized, and 15 resulted to bind heme, with their 
absorption spectra and resonance Raman spectra resembling those of natural 
cytochromes.
112
 
Although the binary code approach seemed well-suited for exploring 
the sequence requirements for designing particular structures, the 
combinatorial underpinnings of this strategy preclude the explicit design of 
catalytic sites. However, also if these sequences were not explicitly designed 
for function, several of these de novo heme proteins were able to catalyze the 
oxidation of TMB (2,2′,5,5′-tetramethyl-benzidine) and ABTS (2,2′-azino-
di(3-ethyl-benzthiazoline-6-sulfonic acid) activity at levels substantially 
above background, with at least one protein that exhibits a rapid catalytic 
turnover. Subsequently, Hatch and co-worker constructed large libraries of 
synthetic genes encoding for four-helix bundle binary patterned proteins. 
Several of these  proteins were found to bind cofactor and/or catalyze 
reactions. Remarkably, the NMR structure of two of these proteins was 
solved, confirming that these proteins form well-folded 4-helix bundles, with 
the hydrophobic residues hidden in the core and the hydrophilic residues 
exposed on the exterior.
113,114
 Recently, these proteins have been used as 
starting point for mutagenesis studies, that were followed by color- based 
screening of peroxidase activity, showing in some case activity 3-fold higher 
than the parental sequence. As a consequence,  these studies demonstrated 
that de novo proteins can be used as a novel feedstock for the evolution of 
enzyme activity.
115
 
Also, one of the first attempts to rationalize the influence of the peptide 
sequence in the modulation of the heme properties is due to Casella and co-
workers, that synthesized several synthetic heme porphyrin models made up 
by a ten residues peptide covalently bound to a porphyrin propionate 
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(through the amino terminal group), that were able to catalyze the oxidation 
of L- and D- tyrosines to o,o’-dityrosine in the presence of hydrogen 
peroxide. Also, the observed oxidation rate was different for the two 
enantiomers, thus highlighting a steroselectivity effect, which is due to the 
interaction with the chiral peptide chain. This effect was modulated by the 
composition of the peptide chain. In fact, reversed preference with respect to 
the oxidation of the two enantiomers was observed for the analyzed peptides.  
Starting from these conjugated, the authors added an L-histidine methyl ester 
residue to the other propionic group, in order to obtain a mono-his complex 
that reproduce the “push” effect of the proximal histidine, in which the distal 
plane of the porphyrin is covered by the deca peptide. They observed an 
improvement of the activity of the model systems, while different 
steroselectivity effects were still observed upon peptide composition.
116,109
 
More recently, the artificial metallo enzyme group, where this project 
has been carried out, designed an artificial five-coordinated heme-complex 
with peroxidase activity, that combines the excellent structural properties of 
four-helix bundle protein scaffolds with the activity of natural peroxidases, 
that was named MP3 (MiniPeroxidase 3) (Fig. 16).
117
 
MP3 is made up by two 41-residue helix-loop-helix (a2) motifs, 
assembled into an antiparallel four-helix bundle, with a covalently bound 
deuteroporphyrin housed in the bundle interior, to obtain an asymmetric 
helix– loop–helix/heme/helix–loop–helix sandwich arrangement, similar to 
the one found in bacterioferritin (an oligomeric protein containing both a 
binuclear iron center and a heme b). The heme environment design was 
based on the structural and functional properties of natural protein HRP. In 
particular, a histidine coordinating residue was introduced to reproduce the 
HRP proximal histidine, (which forms a hydrogen bond with an aspartic 
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side-chain, to improve the imidazolate character of the coordinating His, as in 
HRP proximal site), and an arginine residue was modeled in the distal site, 
mimicking Arg
38
 of HRP, at the right distance from the metal center to assist 
in hydrogen peroxide activation. 
 
 
Fig. 16 Computer model of MP3. Reprinted from Chem. Eur. J., Vol. 18, pp. 15960 – 
15971. Faiella et al., De Novo Design, Synthesis and Characterisation of MP3, A New 
Catalytic Four-Helix Bundle Hemeprotein, Copyright (2012), with permission from 
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
MP3 was characterized by CD spectroscopy, that revealed high helix-
forming propensity, while UV/Vis spectroscopy was used to analyze the 
coordination properties, confirming mono-His coordination above pH 4. In 
addition, kinetic experiment showed that Fe(III)-MP3 has turnover number 
(Kcat) only 8-fold lower than that of HRP, in the experimental conditions for 
maximal activity for each enzyme, while Fe(III)-MP3 Kcat is 10-fold higher 
than that of HRP at neutral pH. 
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1.9. Mimochromes  
The Artificial Metallo Enzymes Group (AMEG) in Naples, where this 
work was carried out, has a long experience in mimicking metalloproteins in 
small peptide-based molecules for the selection of new advanced catalysts. A 
whole family of synthetic heme-protein models, named Mimochromes, was 
developed and fully characterized. These molecules are characterized by a 
sandwich like structure, in which the heme prosthetic group is embraced 
between two helical peptides, that are covalently linked to deuteroporphyrin 
IX (DPIX) through two amide bonds between the heme-propionic groups 
and the -amino groups of two lysine residues (Fig. 17).  
 
 
 
 
 
 
Fig. 17 Mimochrome I. 
The prototype molecule, Mimochrome I, was designed through a 
miniaturization process, applied to the F helix of hemoglobin -chain. This 
miniaturization process was based on detailed analysis of the target segment, 
in order to identify the constituents necessary for reconstruction of the target 
structure. This lead to identification of a nine residue segment (Leu
88
- Leu
96
 
in hemoglobin chain ) as the minimum requirement for complete coating of 
one face of the heme. A histidine residue (His
92
 in hemoglobin) that is 
located in the middle of this segment, binds the heme iron. Two leucine 
residues, at positions i-4 and i+4 relative to the histidine, hydrophobically 
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interact with the heme macrocycle and stabilize the sandwich structure. 
(Leu
88 
and Leu
96
 in hemoglobin) (Fig. 18).
118-120
 
In order to stabilize the  helical conformation, some substitution were made 
to the target sequence:  
 Ser 89 and Cys 93 have been replaced by two alanine residues, Ala2 
and Ala
6
 (the CH3 group of Ala experiences no loss in 
conformational entropy when a randomly coiled polypeptide folds to 
an α-helix)121 
 Glu 90 and Asp94 have been replaced with glutamine and asparagine, 
(Gln
3
 and Asn
7
, respectively)  in order to remove charge that 
destabilize the desired conformation. 
 
Fig. 18 Comparison of Mimochrome I peptide sequence with the sequence of the F helix of 
hemoglobin -chain target segment. 
Finally, a lysine residue was introduced in position 8, in order to 
anchor the heme group. In fact, the peptide chain was covalently linked to 
the heme through amide bonds between the -amino groups of this Lys 
residue and a heme-propionic group. Moreover, two copies of the peptide 
were linked to each heme group, through covalent bond to the two porphyrin 
propionic groups, obtaining a pseudo-C2-symmetric dimer.  
The spectroscopic and structural characterization of Mimochrome I 
indicated that it binds cobalt and iron in a low-spin bis-His-ligated state, as 
intended in the design. CD spectra in the far UV region confirmed the 
peptide chains to be predominantly in an -helical conformation in both the 
apo and metalated species. Moreover, the insertion of metal ion into the 
porphyrin ring gave two diastereomeric forms, differing for the configuration 
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around the metal ion; that were separated as Co(III) complexes by RP-HPLC 
(Fig. 19).  
 
Fig. 19 average molecular structures of Co(III)-Mimochrome I Δ and Λ isomers, as obtained 
from NMR experimental data and RMD calculations. 
Reprinted from Chem. Eur. J., Vol. 9, Lombardi et al., Design of a New Mimochrome with 
Unique Topology, pages 5643-5654., Copyright (2003), with permission from WILEY-
VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
The information derived from Mimochrome I was used for improving 
the design, and develop new models with improved structural and functional 
properties. Two different strategy were followed:  
 
 elongation of the peptide chains at the C-termini, with a four residue 
fragment, modeled in an extended conformation;
122
 
 introduction of amino acidic residues able of forming specific intra-
molecular, inter-chain interactions, that stabilize a single topology of 
the peptide chains around the porphyrin and favor helix formation. 
 
In particular, the last strategy lead to the development of a re-designed 
molecule that adopts a unique topology: Mimochrome IV.
123,124
 In 
Mimochrome IV, an intramolecular inter-chain Arg-Glu ion pair was 
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introduced, in order to favor the formation of only one diasteroisomer. In 
fact, Mimochrome IV differs from Mimochrome I for Glu
1
 and Arg
9
, which 
replace Leu
1
 and Leu
9
, respectively. Additionally, the solvent exposed Ala
2
 
and Ala
6
 in Mimochrome I were replaced by Ser residues in Mimochrome 
IV, in order to further increase the water solubility of the new compound. 
The spectroscopic characterization of Mimochrome IV iron and cobalt 
complexes confirmed a bis-His axial coordination and a predominant helical 
conformation of the peptide chains. Moreover, it indicated the presence of 
the Λ isomer as unique specie. Subsequently, the Co(III) complex was 
structurally characterized both in solution and solid state, confirming the 
unique presence of the Λ topology (Fig. 20). Furthermore, the structural 
characterization evidenced that in the solid state crystal packing interactions 
strongly affects the molecular folding, with intra-chain Glu
1–Arg9 ion pairs 
that are preferred over the designed, and experimentally found in solution, 
inter-chain interactions.  
 
Fig. 20 NMR and X-ray structure of Mimochrome IV. 
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1.10. A heme–proteins model with peroxidase-like 
activity: Fe(III)-Mimochrome VI and its analogues 
More recently, Mimochrome architecture was redesigned with the aim 
of introducing peroxidase like activity. In the new model, named 
Mimochrome VI (Fig. 21), the two chains have different length and 
composition: one is a 14-residue peptide chain, bearing a His residue for 
metal ion coordination, the other is a 10-residue peptide chain, that is devoid 
of a heme-coordinating residue, and therefore may create a cavity around the 
metal ion (distal cavity).
7
 In this peptide, a Ser residue replace the 
coordinating histidine. Serine was chosen in order to facilitate the access of 
small ligands, due to its small side chain. Moreover, the serine side chain is 
also able to act as hydrogen bond donor, and may form hydrogen bond with  
exogenous molecules, stabilizing catalytic intermediates.  
 
Fig. 21Schematic representation of the model structure of Fe(III)–Mimochrome VI. 
 
The two peptide chains embrace the metalloporphyrin, adopting a 
sandwich like structure, similar to that observed to other Mimochromes. In 
terms of secondary structure, the decapeptide was designed to adopt a helical 
conformation, whereas the tetradecapeptide was designed to fold in a short 
helical conformation (residues1–9), a loop (residues 10 and 11) and a short 
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strand (residues 12–14) that folds back (through the loop) to interact with 
the helical part. As in Mimochrome IV, inter-chain ion pairs between the 
carboxylate side chains of glutamate residues (Glu
2
) on one helix and the 
guanidine groups of arginine (Arg
10
) on the other helix were introduced in 
the model, in order to stabilize the tertiary structure. The positively charged 
Arg
10
 and the negatively charged Glu
2
 at the C-terminal and N-terminal 
ends, respectively, with the opposite sign relative to the helix dipole, may 
also provide further stabilization of the secondary structure. Finally, several 
glutamines and a serine were introduced in the solvent exposed positions to 
promote water solubility. 
The spectroscopic and functional characterization indicated that 
Fe(III)-Mimochrome VI is an efficient heme protein model, which displays a 
peroxidase-like catalytic activity. By the use of hydrogen peroxide, it 
efficiently catalyzes the oxidation of several substrates, with a typical 
Michaelis-Menten mechanism and with several multiple turnovers. Fe(III)-
Mimochrome VI peptide framework, despite its small structure (a total of 24 
amino acid residues), confers higher efficiency to the porphyrin cofactor. 
Three important outcomes deserve highlighting: i) Fe(III)-Mimochrome VI 
efficiently catalyzes the oxidation of different substrates, such as ABTS and 
guaiacol, by activating H2O2, and efficiently catalyzes the nitration of 
phenols; ii) Fe(III)-Mimochrome VI displays a very high specific activity 
(104 mol mg
-1
 s
-1
 for ABTS oxidation), with respect to highly purified HRPs 
(91 mol mg
-1
 s
-1
 for ABTS oxidation at pH 4.6); these value highlights both 
its high catalytic efficiency and small molecular mass, compared to natural 
peroxidases that contain more than 300 amino acid residues; iii) Fe(III)-
Mimochrome VI exhibits multiple turnover kinetics: more than 4000 
turnovers within 10 min were observed in the ABTS oxidation. All these 
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features indicate that Fe(III)-Mimochrome VI is an attractive, low-molecular 
weight heme enzyme, which will serve as an excellent scaffold to further 
develop designed heme-based biocatalysts. 
In order to achieve deep insight on the role of the peptide chains in 
modulating the structural and functional properties of Mimochrome VI, 
some point amino acid substitutions in its peptide chains were introduced. In 
particular, amino acid replacement were made into strategic position, with 
the aim of clarify the role of selected residues on the catalytic properties. In 
details, the following substitutions were introduced into Mimochrome VI: 
 
 Glu2Leu in the tetradecapeptide and decapeptide chain;  
 Arg10Leu in the tetradecapeptide and decapeptide chain;  
 Ser6Gly in the decapeptide chain.  
  
These point substitutions were aimed to:  
 break the inter-chain ion pair between the charged residues, thus 
allowing to understand the role of these interactions and, as a 
consequence, of the involved amino acids in the properties of the 
molecule;  
 verify if the serine residue at the distal site of the heme is involved in 
the binding of substrates in the heme pocket.  
 
Five different analogs of Mimochrome VI were synthesized and 
characterized (Rosa Vitale PhD. Thesis, 2013 and Vitale et al., manuscript in 
preparation). 
Their ability to oxidize organic substrates (ABTS) was explored, and 
compared with those of Mimochrome VI and HRP, (table 2).
7,125
 One of this 
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analogues, characterized by the replacement of Glu
2
 on the tetradecapeptide 
with leucine, showed catalytic performance approaching that of HRP. In 
fact, the kcat value observed for this minienzyme is only 7.9 -fold lower than 
HRP, in the experimental conditions for maximal activity for each enzyme, 
whereas the kcat value of Fe(III)-Mimochrome VI Glu
2
Leu TD is about 15 -
fold higher than HRP at neutral pH. Moreover, Fe(III)-Mimochrome VI 
Glu
2
Leu TD shows a significant improvement in the activation of H2O2, 
respect to Fe(III)-Mimochrome VI. In fact, the catalytic efficiency of the 
new developed heme-enzyme for the reducing substrate is about 3- and 4-
fold higher than HRP and Fe(III)-Mimochrome VI, respectively. The 
catalytic activity of Fe(III)-Mimochrome VI E
2
L TD, which is comparable to 
those of complex proteins, demonstrated that its miniaturized structure holds 
essential elements for tuning the iron-porphyrin peroxidase activity. 
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1.11. Aim of the thesis. 
The aim of this PhD project was to engineer new heme-protein 
mimetics that couple high activity with a well-defined three-dimensional 
structure, thus allowing structural characterization. As outlined in the 
previous paragraph, interesting results have been obtained on the heme-
protein models belonging to the Mimochrome family. By using a re-design 
procedure and computational techniques, the catalytic performance of 
Fe(III)-Mimochrome VI were improved. The introduction of point amino 
acid substitutions revealed a key role of some residues in the modulation of 
the heme-model properties. One main drawback of Mimochrome VI and its 
analogues relies in the lack of detailed information of their three-dimensional 
structures. 
 Detailed structural characterization of Mimochrome molecules was 
straightforward for the bis-His–ligated complexes. In fact, as described in the 
previous paragraphs, solution structures by NMR were obtained for the fully 
diamagnetic compound Co(III)-Mimochrome I  and  isomers. Further, for 
Co(III)-Mimochrome IV, the structures in solution and in the solid state were 
solved. 
In the cases of the mono-His ligated complexes such as Mimochrome 
VI attempts to solve the structure on the fully diamagnetic Co(III) complex 
were unsuccessful. In fact, analysis of the Nuclear Magnetic Resonance 
(NMR) spectrum of Co(III)-Mimochrome VI revealed the presence of 
different species in solution (Fig. 22). The complexity of the 
1
H NMR 
spectrum, characterized by the presence of several sets of signals for both the 
porphyrin meso and pyrrole protons (Fig. 22 a) as well as for the 
coordinating His (Fig. 22 b) suggests the presence of different porphyrin 
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systems in solution, which precluded the structure determination. Moreover, 
effort to crystallize this molecule failed. 
 
Fig. 22 1H NMR spectrum  of Co(III)– Mimochrome VI. 
Therefore, even though the catalytic results provide direct evidences 
that the miniaturized structure of Mimochrome VI and its analogues hold 
essential elements for a fine tuning of the iron-porphyrin peroxidase activity, 
a detailed structure-activity relationship analysis cannot be drawn. Thus, a 
very important goal in the development of bio-mimetic heme-containing 
catalysts is to obtain functionally active molecules with a well defined 
structure. This represents an intricate problem since the strategies used for 
the molecular design should take into account all the variables needed to 
specify both the structure and the function. 
 
In this PhD project, two different strategies have been followed in 
order to overcome the structural flexibility of the parent Mimochrome VI 
molecule and design new mimetics:  
 incorporation of non-coded amino acid with -helix stabilizing 
effect; 
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 elongation of the peptide chains, that allows the introduction of a 
large number of intra-chain and inter-chain interactions. 
 
The first strategy was based on the inclusion into Mimochrome VI 
of non coded amino acids, with a well known helix stabilizing effect. In 
this strategy, the new molecule is intended to share with the parent 
Mimochrome VI the same global framework, being characterized by the 
same secondary  structural motifs. For this reason, the strategy dose not 
involved an ex-novo design of the protein scaffold, and does not required 
an extensive re-design process. The designed Mimochrome VI –2U1L 
was synthesized and the analysis of its Co(III)-complex structural 
properties carried out by 
1
H-NMR spectroscopy.  
 
The second strategy, involved the design of a new protein 
framework, characterized by a different organization of the secondary 
structure elements. In particular, the peptide chains were elongated in 
order to include a greater number of intra-chain and inter-chain 
interactions, aimed to stabilize the global fold. This strategy required an 
extensive re-design process, that involved several cycle of re-design and 
energy minimization. To this aim, the X-ray structure of a Co(III)-
Mimochrome IV was used as template. In order to simplify the design and 
characterization, in this thesis a symmetric model, named Mimochrome 
VII, characterized by a bis-histidine metal binding site was obtained. The 
NMR structure of this symmetrical model has been used as a framework 
to design an asymmetrical penta-coordinated model. In particular, in 
Mimochrome VII was created a distal cavity that contains an arginine 
residue, mimicking Arg
38
 of Horseradish Peroxidase (HRP), and a non-
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coordinating His residue to mimic His
42
 of HRP. The structural 
characterization of this new model is under course. 
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Results and 
discussion 
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2. Development of a heme-protein model that incorporate -
aminoisobutyric acid (Aib), a non-coded amino acid. 
2.1. Mimochrome VI-2U1L 
The first strategy toward the engineering of new heme-protein 
mimetics was devoted to introduce into Mimochrome VI some structural 
constraints aimed at stabilizing the structure while preserving functionality.  
As previously described, Mimochromes are composed of two peptide 
chains that surround the heme group and have the following two main 
features: i) the peptide chains are in -helical conformation; and ii) the helix 
-heme-helix sandwich has a covalent structure. The use of -helical peptides 
able to cage the heme group, has been and still remains the focus of the 
majority of the works in the field of heme-protein mimetics, because the -
helix motif is a recurring structural motif that surround the heme cofactor in 
numerous natural hemeproteins. Herein, -aminoisobutyric acid, Aib (U), a 
well-established helix stabilizing non-coded amino acid that occurs 
extensively in peptides produced by microbial sources (for example  in the 
antibiotic peptides chlamydocin, alamethicin, antiamoebin, emerimicin, and 
zervamicin), has been introduced in Fe(III)-Mimochrome VI, in order to 
favour the formation of the helical structure. 
In fact, the replacement of the proton on the C

 atom in an alanine 
residue with another methyl group severely restricts the possible rotations 
about the  N-C and C-C' bond, forcing the Phi and Psi values to fall in two 
very restricted regions near -57°, -47 ° and +57°; +47°, corresponding to  α-
helix  or 310-helix  structures (Fig. 23). Aib oligomers form exclusively 310-
helices, and the strong propensity to form 310-helices is maintained when the 
Aib composition exceeds 50%. On the contrary, when the Aib content is less 
than 50%, mixed α/310-helical structures can occur, and several factors such 
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as length, composition and exact sequence, favor one or the other helix type, 
with peptide longer more than 6 residues (between 6 and 20 residues) that 
generally fold into predominantly α-helices.126,127 
 
Fig. 23 a) -aminoisobutyric acid, Aib (U); b) Ramachandran chart of Aib residue. 
 
In this work, two Aib residue were introduced in Mimochrome basic 
structure, in order to favor helix formation and overcome the structural 
mobility that precluded the structural characterization of the original model. 
In particular, these substitutions were done on the most active analogues of 
Mimochrome VI, Fe(III)-Mimochrome VI E
2
L TD. 
This new mimetic, as the parent molecule, exhibits a mono-histidine 
five coordination to the heme, and it is made up of two peptide chains of 
different length and composition covalently linked to deuteroporphyrin IX 
via amide bond between  the -amino groups of a lysine residue and the 
heme-propionic groups 
The new model, Mimochrome VI-2U1L (Fig. 24), shares with the original 
template, Mimochrome VI, the following features: 
Results and discussion: chapter 2 
57 
 
 one chain is a decapeptide intended to fold in  helical 
conformation; 
 one chain is a tetradecapeptide intended to fold as follows: α-helix 
(1-9), loop (10-11), β-strand (12-14). This peptide chain bears an 
histidine that acts as an axial ligand to the heme central ion. 
 Glu2 on tetradecapeptide was replaced with Leu. This substitution 
removes the Arg10-Glu2 ion pair interaction, thus enabling Arg10 to 
participate in the catalytic cycle, mimicking the Arg38 of the HRP cycle 
 
Respect to the template Mimochrome VI E
2
L TD, Gln
3
 and Ser
7 
on the 
decapeptide were replaced with two Aib residues, with the aim of stabilizing 
the helix, and overcome conformational mobility. 
 
Fig. 24  Mimochrome VI-2U1L a) three-dimensional model; b) primary sequence. 
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2.2. Synthetic strategy: Mimochrome VI-2U1L apo form 
Mimochrome VI-2U1L was synthesized as previously described for 
Mimochrome VI.
7
 Peptide chains were synthesized in solid phase, by using 
9-fluorenylmethoxycarbonyl (Fmoc) protection strategy. The selective 
deprotection from (4-methoxyphenyl)diphenylmethyl group (Mmt) of Lys
9
 
residues on the two chains is required before their cleavage from the resin. In 
this way, it is possible to obtain the peptides with the free Lys
9
 and all other 
residue side-chains still protected. The peptides were then coupled to 
deuteroporphyrin IX in solution to afford, after side chain deprotection, 
Mimochrome VI-2U1L. 
The synthetic protocol is made up of three main steps (Fig. 25): 
 synthesis of the monosubstituted intermediate (decapeptide 
deuteroporphyrin-IX). Care was taken to minimize the formation of 
bis-substituted product by adding dropwise the solution containing 
the peptide to a large excess of DPIX. 
 synthesis of the disubstituted intermediate (decapeptide-DEUIX-
tetradecapeptide);  
 deprotection of the disubstituted intermediate to obtain the apo form, 
Mimochrome VI-2U1L. 
 
Fig. 25 Schematic representation of the synthetic strategy. 
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The monosubstituted intermediate was analyzed by RP-HPLC, on a C-
8 column, using a linear gradient elution of water/acetonitrile 0.1% TFA.  
The chromatographic profile, shown in Fig. 26, evidences the presence 
of two peaks of similar intensity at Rt of 26.97 and 27.23 minutes, 
respectively.  
 
Fig. 26. Mimochrome VI-2U1L apo form chromatogram. 
Further, the mass spectra of the two peaks showed similar behaviors: an 
intense peak at m/z 1147.0 ([M-3H]
3+
/3), a second peak at m/z 860.5 ([M-
4H]
4+
/4) and a third peak at 866.6 ([M-5H]5+/5). These values are in agreement 
for both peaks with the mass expected for Mimochrome VI-2U1L (3437.8 Da).  
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Fig. 27. Mimochrome VI-2U1L apo form ESI-MS spectra a) peak at Rt of 26.97 min; b) 
peak at 27.23 min 
Therefore, we hypothesized that the apo form is actually constituted by 
an equimolar mixture of two constitutional isomers. In fact, in the first step 
of the synthetic protocol, coupling of the decapeptide to the 
deuteroporphyrin IX can occur at either the 2 or the 18 propionic group (see 
Fig. 28). As a consequence, the monosubstituted intermediate decapeptide 
deuteroporphyrin-IX is an equimolar mixture of two constitutional isomers 
mono-substituted at position 2 or 18 of the porphyrin ring. The subsequent 
coupling of the tetradeca-peptide to the monosubstituted intermediate 
decapeptide deuteroporphyrin-IX give an equimolar mixture of two 
Mimochrome VI-2U1L constitutional isomer (see Fig. 28). The presence of 
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the two Aib residues in this molecule, respect to the parent Mimochrome VI 
E
2
L TD, may induce slightly different retention times for the two specie, 
thus enabling their separation. In fact, even though the synthetic protocol 
used for Mimochrome VI and its analogues can also afford to an equimolar 
mixtures of the 2(18)- decapeptide, 18(2)-tetradecapeptide constitutional 
isomers, their separation was not detectable by RP-HPLC.  
 
Fig. 28Constitutional isomers of the Mimochrome VI-2U1L apo form. 
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2.3. Co(III)-Mimochrome VI-2U1L 
With the aim of structurally characterize the new compound, the 
diamagnetic Co(III) ion was inserted into Mimochrome VI-U1L apo form 
mixture. Cobalt (III) was inserted into the molecule using Co(II) acetate 
according to the literature method.
45
 Fig. 29 shows the HPLC chromatogram 
of the reaction mixture. Four peaks, named peak a, peak b, peak c and peak 
d, were detected. No substantial changes in the ratio between the peak areas 
of these species occurred either by extending the reaction time or by favoring 
Co(II)Co(III) air oxidation.  
 
Fig. 29 RP-HPLC chromatogram of Co(III)- Mimochrome VI-2U1L. 
The four species were then separated by preparative HPLC and separately 
analyzed (Fig. 30). The ESI-Mass spectra for all the peaks revealed a 
molecular weight of 3494.9 Da in agreement with the mass expected for 
Co(III)-mimochrome VI-2U1L. The UV-visible spectra of the four peaks 
showed similar behaviors, both for the intensities and positions of the Soret, 
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 and  bands. The UV-visible spectral data are in agreement with the 
presence of a Co(III) porphyrin complex characterized by a mono-histidine 
axial coordination, for all the four peaks.  
 
Fig. 30. RP-HPLC chromatogram of the four Co(III)-Mimochrome VI-2U1L species after 
purification. 
2.4. Co(III) -Mimochrome VI-2U1L: NMR spectroscopy 
The four Co(III)-Mimochrome VI-2U1L species, purified by 
preparative RP-HPLC, were separately analyzed by Nuclear Magnetic 
Resonance.  
The analysis was carried out in H2O/TFE 60/40 (v/v).  The 
1
H spectra 
are shown showe a single set of resonances for the deuteroporphyrin protons, 
and two sets of resonances for the peptidic part. The intensities of the 
deuteroporphyrin proton resonances as compared with those of the peptide 
chains are in the expected 1:2 ratio.  
A careful examination of the NMR spectra revealed that a complete 
separation of the four species was not obtained. Fig. 31 shows the high field 
region of 
1
H NMR spectra, where resonate the His imidazole protons.  
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Fig. 31 High field region of Co(III)-Mimochrome VI-2U1L species 1D 1H NMR spectra 
acquire in water/TFE 60/40 (v/v). The signals showed are attributed to the His ε-CH and δ-
CH imidazole protons, that experience an extremely large ring current effect and appear in 
the high-field region of the spectrum.  
In particular, while peak a seems to contain only one species, the 
NMR spectrum of peak b displays a predominant species with a small 
contamination (about 5%) of the species deriving from peak a. On the 
contrary, peak c and peak d show more complex spectra, due to the higher 
degree of contamination and to the presence of more than two species in 
solution. For this reason, a complete resonance assignment and structural 
characterization was achieved only for the first two peaks.  
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2.5. Co(III)-Mimochrome VI-2U1L resonance 
assignment 
Peak a  
Resonances assignment was accomplished by 2D experiments 
(NOESY,
128
 TOCSY,
129
 DQF-COSY
130
) by means of the sequential 
technique for both deuteroporphyrin and peptide protons. 
Histidine sidechain protons were unequivocally assigned. The -CH 
and -CH imidazole protons experience an extremely large ring current 
effect and appear in the high-field region of the spectrum. The -CH 
resonances were easily identified on the basis of medium range NOE with 
the His
6
 ’-CH2 protons.  
In the TOCSY experiment the -CH signal at  = -0.49 is correlated 
to -CH imidazole proton at  = -0.16 ppm. This last resonance is in strong 
dipolar contact with a resonance at  = 9.23 ppm, which was assigned to the 
imidazole -NH of the histidine at position 6 of the tetradecapeptide chain. 
All deuteroporphyrin proton resonances were unambiguously 
assigned, including those of the propionic groups, that exhibited clearly 
distinct resonances. In particular, the deuteroporphyrin assignment was 
easily performed following the NOE connectivities around the ring and 
starting from the 5H proton (at  =10.50); it is the only proton in dipolar 
contact with the two methyl groups (3-CH3 and 7-CH3) (see Fig. 32) for 
deuteroporphyrin numbering).  
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Fig. 32 Deuteroporphyrin IX. 
Chemical shifts of peptide chains show CH resonances significantly 
up-field shifted, relative to their random coil values (see Fig. 33),
131,132
 and it 
is also shown by amidic NH, as well as by sidechain protons (data not 
shown). It is reasonable to assume that these deviations are due to the 
peptide secondary structures.
132-134
 Furthermore, this effect is most 
pronounced for the tetradecapeptide chain (bearing the coordinating 
histidine), thus we could suppose that this peptide chain experiences 
deuteroporphyrin ring current too.  
 
Fig 33Chemical shift index ΔδCH = (δosb - δ randomcoil) of peak a. 
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Indeed, the pattern of the NOE connectivities strongly supports the 
presence of a quite regular structure for the tetradecapeptide chain.  
A total of 395 NOE connectivities were measured. The relative 
intensities of the structurally considerable NOE crosspeaks are shown in Fig. 
34. 
. 
Fig. 34 Co(III)-Mimochrome VI-2U1L peak a:summary of NOE contacts. Bar thickness is 
proportionally related to the NOE intensity. 
A continuous stretch of dNi-Ni+1 were monitored. Furthermore, several 
medium- and long-range contacts were unambiguously observed throughout 
the peptide sequence such as relatively strong di-i+3, di-Ni+3, and weaker di-
Ni+4 NOEs. 
These data are consistent with an -helix comprising residues 1-10, 
while it is possible to hypothesize a less regular structure n  the C-terminal 
region (Lys
11
-Leu
14
). 
From a structural point of view, the determination of the His sidechain 
orientation with respect to the peptide backbone is of interest. Several NOE 
contacts of the histidine protons with Leu
2
 and Leu
5
 and Lys
9
 protons were 
observed. Some of these contacts are unambiguous since they are caused by 
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the -CH and -CH protons. Unexchangeable -NH is also clearly visible, 
indicating that this proton is buried in the interior of the molecule and/or 
hydrogen-bonded. This further confirms that the cobalt(III) axial ligation 
occurs through the unprotonated imidazole N atom of the histidine, as 
already reported for other Mimochrome Co(III)  complexes.
119,124 
Furthermore, the -CH and-CH imidazole protons have different 
connectivities with the deuteroporphyrin protons. These connectivities were 
crucial to define the orientation of the His
6
 imidazole ring with respect to the 
deuteroporphyrin ring. In particular the following dipolar contacts are 
observed: εCH ↔ 8H, εCH ↔ 10H, εCH ↔ 12 CH3, εCH ↔ 13H, εCH ↔ 
15H, δCH ↔ 20H,  δCH ↔ 3CH3, δCH ↔ 5H.  These connectivities 
indicate that the imidazole plane intersects the deuteroporphyrin ring through 
the 4 and 14 positions of the deuteroporphyrin ring (figure nnn). 
Finally, it was easy to identify the tetradecapeptide chain as the one 
bound to propionyl group in position 2 on the basis of several NOE contacts 
between Lys
9
 sidechain and propionic ,’- and ,’-CH2 protons (Fig. 35)  
Regarding the decapeptide chain, as already reported, even if the CH 
chemical shifts are up-field shifted respect their typical random coil value, 
and indicative of an helical conformation, the NOEs data are not completely 
unambiguous due to severe overlaps. In particular, a continuous stretch of 
dNi-Ni+1 NOEs along the entire peptide sequence, and some medium-range 
contacts such as di-i+3, dNi-Ni+2 were monitored and corroborated  the 
existence of an organized structure of the peptide chain. Thus, at this stage, it 
was not possible to perform a complete structural analysis on the 
decapeptide chain. Different experimental conditions, such as temperature, 
pH, solvent, could help to overcome overlapping phenomena.  
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As  for the tetradecapeptide chain, the NOE contacts between Lys
9
 
sidechain and propionic ,’- and ,’-CH2 protons, allowed us to establish 
that this chain was linked to the propyonil group in position 18 of the 
deuteroporphyrin ring. 
 
Fig. 35. Details of NMR NOESY (Nuclear Overhauser Effect ) spectrum and covalent 
structure of Co(III) -Mimochrome VI-2U1L peak a. 
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Peak b 
The strategy for assignment was similar to that used for the peak a. 
The elements of secondary structure were first delineated using information 
provided by CH conformational shifts and NOE data. All residues, and 
particularly His
6
, showed secondary chemical shifts of CH protons with 
negative values, characteristic of a-helical structures. CH proton chemical 
shift changes are reported in bar charts in Figure 36.  
 
Fig 36. Chemical shift index Δδ(CH) (δosb - δ randomcoil) of peak b. 
 
This trend was observed for both peptide chains, and it was reasonable 
to assume that these deviations were due to peptide secondary structure. In 
particular, it was hypothesized the presence of helical conformation. 
However, as already reported for peak a, we observed a complete pattern  of 
unambiguous NOE connectivities (see Fig. 37) for the teradecapeptide chain 
that allowed us to define, with great confidence, its structure.  
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Fig. 37 Co(III)-Mimochrome VI-2U1L peak b:summary of NOE contacts. Bar thickness is 
proportionally related to the NOE intensity. 
On the contrary, severe overlaps allowed us to delineate the structure 
of decapeptide chain only in a qualitative manner.  Furthermore, several His
6
 
imidazole proton NOEs contacts allowed us to correctly orient the imidazole 
with respect to the peptide backbone and with the deuteroporphyrin ring.  In 
particular,  the histidine exhibits εCH ↔ 8 H, εCH ↔ 10H, εCH ↔ 12 CH3,  
δCH ↔ 20H NOE dipolar contacts. These connectivities indicate that the 
imidazole plane intersects the deuteroporphyrin ring through the 10 and 20 
positions of the deuteroporphyrin ring (see Fig. 32 for deuteroporphyrin 
numbering). 
Finally, the NOE contacts between Lys
9
 sidechain and propionic 
,’- and ,’-CH2 protons were crucial to identify the tetradecapeptide 
chain as the one bound to propionyl group in position 18, and the 
decapeptide chain the one linked to the propionyl group at position 2 (Fig. 
38).  
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Fig. 38. Details of NMR NOESY (Nuclear Overhauser Effect ) spectrum and covalent 
structure of Co(III)-Mimochrome VI-2U1L peak a. 
 
2.6. Co(III)-Mimochrome VI-2U1L structural 
calculation 
On the basis of the dipolar connectivities, using CYANA software,
135
 
we were able to determine the solution structures. In particular, for both 
compound, we were able to solve the structure of the tetradecapeptide-
porphyrin moiety, obtaining an ensemble of 20 tightly clustered structures 
(Fig. 39). 
The 20 conformers constituting the final family converged to the same 
topology, with an average total target function of 0.07± 5.16 10
-2
Å and 0.31 
± 5.16 10
-2
Å for peak a and b, respectively (table 3 and table 4). 
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Table 3 NMR statistics of the Co(III)-Mimochrome VI-2U1L 
peak a 20 best NMR structures. 
Rmsd to averaged coordinates Å 
backbone  0.35± 0.15  
all heavy  0.93 ±0.19 
target function (Å
2
) 0.074 ±1.73·10
-3 
 
Ramachandran plot statistics (%) 
most favoured regions 91.7 
additional allowed regions 8.3 
generously allowed region 0.0 
disallowed regions 0.0 
 
 
 
 
 
 
 
 
 
Analysis of the ensemble of the structures by PROCHECK-NMR
136
 
revealed that 92 % backbone angles fall within the most favored regions of 
Ramachandran plot, 8% in additional allowed regions , for both peak a and 
b. 
Superposition of the best 20 structures on the mean coordinates gave, 
for peak a, an average root mean square deviation (rmsd) of 0.35±0.15 Å for 
all backbone atoms and 0.93±0.19Å for all heavy atoms. Similarly the 
Table 4 NMR statistics of the Co(III)- Mimochrome VI-2U1L 
peak b 20 best NMR structures. 
Rmsd  to averaged coordinates   Å 
backbone  0.22± 0.08 
all heavy  0.92 ±0.11 
target function (Å
2
) 0.24 ±3.91·10
-4 
 
Ramachandran plot statistics (%) 
most favoured regions 91.7 
additional allowed regions 8.3 
generously allowed region 0 
disallowed regions 0.0 
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superposition of the best 20 structures for peak b gave, an average root mean 
square deviation (rmsd) of 0.22±0.08 Å for all backbone atoms and 
0.92±0.11 Å for all heavy atoms. 
Peak a and peak b are characterized by a tetradecapeptide chain with 
very similar structure. The  and  angles from Asp1 to Lys9 are very close 
to those expected for a right-handed -helical conformation (Fig. 40).  
 
 
Fig. 39 Solution structure of the tetradecapeptide-porphyrin moiety of Co(III)-Mimochrome 
VI-2U1L a) peak a; b) peak b.  
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The helical structure of the peptide chains is such that Leu
2
, Leu
5
, His
6
 
and Lys
9
 sidechains are facing the deuteroporphyrin plane. These residues 
create a partially open hydrophobic cage around the imidazole ring.  
In the C-terminal region (segment 11-14), designed to fold in extended 
conformation, a distortion from -helical structure is observed. In particular, 
this distortion is more evident around Arg
10
-Lys
11
 segment. 
 
 
Fig. 40 Ramachandran plot of the tetradecapeptide-porphyrin moiety of Co(III)-
Mimochrome VI-2U1L a) peak a; b) peak b.  
 
The dihedral angle values of histidine side chain are χ1 = -90.9° and -
75.5°, χ2 = 1115.7°and 95°, for peak a and peak b, respectively. These 
values were similar to those observed for the side chain conformation 
adopted by helical histidine-coordinating residue in heme-proteins, and are 
also in agreement with the hydrogen bond formation between histidine NHδ1 
proton and the backbone carbonyl of the amino acid at position i – 4 (Fig. 
41).
137
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Fig 41. Conformational statistic for histidine derived from the Protein Data Bank select 
nonredundant protein database. Population distribution derived for all histidines, despicted 
in green, correspond to the left axis and distribution derived from heme ligand histidines, 
depicted in red, correspond to the right axis.  Copyright © 2004, The National Academy of 
Sciences.137 
 
All peptide bonds are trans and all sidechain conformations are 
staggered. An almost regular COi- NHi+4 pattern of intramolecular hydrogen 
bonds is observed for both peptide chains, except for the lack of His
5
-CO-
Arg
9
-NH hydrogen bond and for the presence of two COi-HNi+3 hydrogen 
bonds at the N-terminal. In addition, the NH of Lys
9
 form hydrogen bonds 
with the CO groups of His
5
. and the NH of Arg
9
 and Asn
7
, respectively. 
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3. Development of artificial heme-proteins models with 
elongated peptide chains: Mimochrome VII  
3.1. Design 
With the aim of developing catalytically active molecules with a well 
defined structure, a second strategy was followed in this PhD thesis. This 
approach involved the design of a new protein framework, characterized by a 
different organization of the secondary structure elements.  
To this aim, the X-ray structure of Co(III)-Mimochrome IV was used 
as template to engineer a new heme mimetic, Mimochrome VII (Fig. 42).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 42 Molecular structure of Co(III)-Mimochrome IV and molecular model of Co(III)-
Mimochrome VII. 
Co(III)-Mimochrome IV was fully characterized both in solution and 
in the solid state. The structural characterization of Co(III)-Mimochrome IV, 
at the atomic level, confirmed that most of the factors considered in the 
MIMOCHROME IV MIMOCHROME VII 
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design were actually effective in stabilizing the molecules. In the solid state, 
as well as in solution, Co(III)-Mimochrome IV shows the designed sandwich 
structure, with the peptide chains in a helical conformation. Indeed, a 
different orientation of the peptide chains is observed for the solution and X-
ray structures. In fact, while the crystallography structure shows two intra-
chain ion pair interactions, between the carboxylate side chains of glutamate 
residues, Glu
1
, and the guanidine groups of arginine, Arg
9
, the solution 
structure shows inter-chain interactions between the carboxylate groups of 
Glu
1
 on one helix and the guanidine groups of Arg
9
 on the other helix, as 
intended in the design. 
The structural information derived from Mimochrome IV was 
fruitfully applied for improving the design, and to further stabilize the 
secondary and tertiary structure. Starting from the Co(III)-Mimochrome IV 
X-ray structure, we elongated the peptide chain and modified the sequence 
by introducing several residues able to make inter-chain and intra-chain 
interactions. The design process lead to the development of a new heme-
protein mimetic, Mimochrome VII, with the following features (Fig. 42): 
 it is made up of two equal 17-residue peptide chains anchored to the 
heme group. Each chain bears an histidine residue that acts as axial 
ligand to the heme central ion, providing a symmetrical six-
coordinate coordinated metal binding site; 
 the chains fold into two secondary structure motifs (Fig. 43): 
 the C-terminal residues (from 6 to 17) were modeled to 
stabilize an α-helix; 
 residues at N-terminus (from 1 to 5) were modeled in an 
extended conformation, folding back to interact with the 
helical part. This segment will be useful in the design of 
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asymmetrical penta-coordinated models, because it may 
ensure further protection of the heme from bleaching, during 
the catalytic cycle. 
 
Fig. 43: schematic representation of Mimochrome VII  secondary structure. 
To induce the desired secondary structure, amino acid with high helix 
propensity were inserted at the C-termini, amino acid with low helix 
propensity were placed at N-termini (Fig 44); 
 
Fig. 44 Schematic representation of Mimochrome VII molecule. The 
metalloporphyrin moiety is depicted as a black line. Below each amino acid, helix 
propensity according to Pace and Scholtz is reported.121 The results are presented as 
∆(∆G) values relative to Ala, which has been set to zero because it is usually the 
amino acid with the most favorable helix propensity. The coordinating histidine 
residues are highlighted in red, the lysine residues covalently linked to DP IX are 
highlighted in green. 
The peptide chains were designed to both fold in the intended tertiary 
structure and create the desired coordination shell around the heme. The 
sequence was modified in order to introduce several residues able to make 
inter-chain and intra-chain interactions in strategic positions. Computational 
methods based on molecular mechanics were used in order to refine the 
structure into a local energy minimum, and through an iterative process of 
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design and energy minimization, the design process culminates in the 
development of a new heme-protein mimetic, with the following features: 
 
1. the amino acid composition was designed to contain hydrophilic 
residues in all the solvent exposed positions (Glu
10
, Glu
13
, Lys
14
, 
Lys
17
) and hydrophobic residues were placed in the positions 
facing the porphyrin moiety (Leu
12
, Leu
16
). 
 
2. Glu and Lys residues were placed at positions 10, 13 and 14, 17 
of the sequence, respectively, in order to engineer two helix-
stabilizing i, i+4 ion pair interactions in each helix. 
 
3. a tryptophan residue was placed at the N-termini extended 
segment of each chain. By forming hydrophobic interaction with 
the porphryn, these tryptophan residues favour the folding back 
of the peptide chains. 
 
4. two inter-chain ion pair were introduced (Fig. 45), to avoid the 
formation of multiple diastereomeric forms, which were observed 
in early Mimochrome mimetics 
119
 In fact, due to the linker 
flexibility between the peptide and the porphyrin cofactor, two 
different orientations of the peptide chains are allowed: each 
peptide chain can be arranged above or below the porphyrin 
plane, giving rise to different diasteromeric configurations 
around the iron center. To favor the formation of one of these 
configurations,
124
 two ion pair interations have been introduced 
between arginine and aspartic acid residues, that were placed 
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according to intrinsic helix dipole, with the negative residue at the 
N-terminus of the helix (Asp5), and the positive residue at the C-
terminus (Arg 15); 
 
 
 
Fig. 45 Fe(III)-Mimochrome VII model. Intra-chain  a) and inter-chain b)  ion pair 
interactions are highlighted. 
5. N- and C-terminal ends were acetylated and amidated, 
respectively, to avoid the presence of end charges that might 
affect the helix stability. 
 
3.2. Synthesis and purification 
The new compound was synthesized similarly to other Mimochromes, 
by using previously developed protocols. The synthetic strategy is 
schematically reported in Fig. 46. The 17 amino acid peptide was 
synthesized using solid-phase methods with 9-Fluorenylmethoxycarbonyl 
(Fmoc) protocol. After selective deprotection of Lys
11
, the peptide was 
cleaved from the resin, without removing the other side chain protecting 
groups. It was then coupled to deuteroporphyrin IX in solution. The resulting 
miomicohrome VII apo form was completely deprotected and purified by 
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RP-HPLC. Finally, iron and cobalt ions were inserted into the porphyrin 
ring, according to literature procedures. Electrospray ionization mass 
Spectrometry (ESI-MS) and ion trap (IT) -  time-of-flight (TOF) mass 
spectrometry (LCMS-IT-TOF) were used to confirm the identity of the 
products. Experimental details on synthesis, RP-HPLC purification and ESI-
MS spectra are reported in experimental section. 
 
Fig. 46 Synthetic strategy. 
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3.3. CD Spectroscopy 
The conformational features of Co(III)-Mimochrome VII and Fe(III)- 
Mimochrome VII complexes were investigated using CD spectroscopy. Fig. 
44 shows the UV-region CD spectra of both complexes in 10.0 mM 
phosphate buffer solution (pH=7), and in phosphate buffer solution (pH=7) 
containing 30% TFE (v/v) (Fig. 47). Table 5 reports their CD parameters 
along with the CD parameters of Fe(III)- and Co(III)-Mimochrome IV 
complexes.
123
 
 
Fig. 47: CD spectra in the far/UV region of a) Co(III)-Mimochrome VII in phosphate buffer, 
10 mM, pH 7(blu line) and in phosphate buffer, 10 mM, pH 7/30% TFE (v/v) (pink line); b) 
Fe(III)-Mimochrome VII in phosphate buffer, 10 mM, pH 7(blu line) and in phosphate 
buffer, 10 mM, pH 7/30% TFE  v/v) (pink line). 
The CD spectral behaviors for both Co(III)- and Fe(III)-Mimochrome 
VII complexes clearly indicate the peptides to be in helical conformation, as 
designed. The shapes and relative intensities of the minima around 222 and 
206 nm, as well as the 0 crossover and maximum around 190 nm, indicate 
the peptides to be helical in both Fe(III)- and Co(III)- complexes. The helical 
content slightly increases upon TFE addition (up to 30%) and it is quite 
comparable to that of the corresponding Mimochrome IV complexes (see 
Table 5). This finding clearly indicates that the amino acid substitutions 
made in the Mimochrome IV sequence did not perturb the helical 
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conformation of the peptide chains, but they play a favorable contribution in 
the helix formation.  
Table 5 CD parameters of Mimochrome VII compared with the values  for Mimochrome 
IV. 
 
[θ]min *10
-3 
(, nm) 
0 
(nm) 
[θ]222 *10
-3 
(, nm) 
[θ]max*10
-4 
(, nm) 
Fe(III)- Mimochrome VII     
10 mM phosphate buffer pH 7 -9.1 (207) 199 -7.3 1.1 (190) 
phosphate buffer /TFE 70/30 (v/v) -12.3 (208) 200 -9.2 2.0  (190) 
Co(III)-Mimochrome VII     
10 mM phosphate buffer pH 7 -9.8 (208) 199 -7.4 1.4 (190) 
phosphate buffer/TFE 70/30 (v/v) - 14.0(208) 200 -9.7 2.5 (191) 
Fe(III)- Mimochrome IV     
phosphate buffer/TFE 70/30 (v/v)  -11.2 (207) 200 -9.5 1.7 (193) 
Co(III)- Mimochrome IV     
phosphate buffer/TFE 70/30 (v/v) -15.2 (207) 200 -11.4 2.2 (192) 
 
The 222 values for both Co(III) and Fe(III) complexes are lower than 
that expected for an almost complete helical conformation. Even though the 
222 value can be correctly applied to calculate the helix percentage in 
proteins, it fails to estimate the helix contents in small peptides,
138
 for which 
the  ratio of the minimum at 222 nm to the minimum at shorter 
wavelengths, the position of this last minimum and the crossover wavelength 
0 are all indicative of helix propensity. Further, the interactions between the 
heme transitions and those of the peptide backbone amide dipoles may 
influence the far-UV CD spectra. The value of [θ]ratio, the  ratio of the 
minimum at 222 nm to the minimum at shorter wavelengths, is around 0.8. 
Typically, in the a-helix the [] ratio value is around unity. The observed 
values of the [θ]ratio could be interpreted as a small 310-helical distortion, as 
reported in literature.
139
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3.4. UV-vis spectroscopy 
UV/Vis spectroscopy was used to determine the coordination 
geometry, the spin and oxidation states of the metal ion inserted into the 
porphyrin ring. Figure 48 shows the UV/Vis spectra of Fe(III)-Mimochrome 
VII (a and b) and Co(III)-Mimochrome VII (b and c), in 10.0 mM phosphate 
buffer solution, pH 7, and 10 mM phosphate buffer, pH 7/TFE 70/30 (v/v), 
respectively.  
 
Fig. 48 UV-vis spectra of Fe(III)-Mimochrome VII a) in 10 mM phosphate buffer, pH 7, b) 
10 mM phosphate buffer, pH 7/ TFE 70/30 (v/v); Co(III)-Mimochrome VII in 10 mM 
phosphate buffer, pH 7, d) 10 mM phosphate buffer, pH 7/ TFE 70/30 (v/v). 
The position and the relative intensities of the Soret,  and  bands give 
useful information on the metal ion coordination state.
6,45
 For the iron 
derivative at pH 7, the positions of the Soret and low energy bands at 403 
(=7.4 × 104 M-1cm-1) and 524 nm (=4.6 × 103 M-1cm-1), respectively, with 
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a shoulder at 570 nm are indicative of a ferric low-spin state, with a bis-His 
axial coordination.
6,45 
For the cobalt complex at pH 7,  the positions of the 
Soret,  and  bands at 417 nm (=1.2 105 × M-1cm-1), 526 nm (=8.4 103 × 
M
-1
cm
-1
) and 557 nm (=6.0 103 × M-1cm-1) respectively, and the extinction 
coefficient ratio between the  and  bands are characteristic of an 
octahedral Co(III).
119,122,140,141
 
All the spectral data (see table 6) are very similar to those found for the 
Fe(III) and Co(III) complexes of Mimochrome IV. 
Table 6. UV-vis spectral data of Fe(III)-Mimochrome VII and Co(III)-Mimochrome VII 
Specie 
p
H 
λSoret, nm 
(ε, M-1 cm-1) 
λVisible, nm) 
(ε, M-1 cm-1) 
Fe(III)-Mimochrome VII    
10 mM phosphate buffer 7 403 (7.4*104) 524, 570 (4.6*103, 1.8*103) 
phosphate buffer /TFE 70/30 (v/v) 7 401 (1.0*105) 526, 557 (5.6*103, 3.5*103) 
Co(III)-Mimochrome VII    
10 mM phosphate buffer 7 417 (1.2*105) 526, 557 (8.4*103, 6.0*103) 
phosphate buffer /TFE 70/30 (v/v) 7 416 (1.2*105) 525, 557 (8.1*103, 6.0*103) 
Fe(III)-Mimochrome IV    
phosphate buffer 7 401 (1.0*105) 522, 560 (6.2*103) 
Co(III)-Mimochrome IV    
phosphate buffer 7 415 (1.6*105) 525, 556 (1.2*104, 8.2*103) 
 
In order to determine the coordination properties of the Fe(III) 
complex, the UV-vis spectra at different pH (from pH 1 to 7) were recorded 
in water/TFE solution 70/30 (v/v). Fig.49 shows the UV/Vis spectra of 
Fe(III)-Mimochrome VII at pH 7 (blue line), and at pH 1.4 (red line). Figure 
47 reports the plot of the molar extinction coefficient intensities of the band 
at 388 nm (red line) and 401 nm (blue line) as a function of the pH.  
At pH 1.4, the electronic spectrum shows the Soret band at 388 nm ( ε 
~ 1.0 × 10
5 
M
-1
 cm
-1
), the Q bands at 501 and 528 nm  (ε ~ 6.4 × 103 M-1 cm-
1
 and ~ 5.7 × 10
3 
M
-1
 cm
-1
 ), and a CT (charge-transfer) band at 617 nm (ε ~ 
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2.3 × 10
3 
M
-1
 cm
-1
). This spectrum is in indicative of a high-spin ferric state, 
with two weak ligands (i.e., water molecules) axially coordinated to the iron 
 
Fig. 49 Fe(III)-Mimochrome VII  Uv-vis spectra at pH 7 (in blue) and at pH 1.4 (in red). 
 
Fig. 50 The dependence of Fe(III)-Mimochrome VII molar extinction coefficient (ε) at 388 
nm (in red) and at 401 nm (in blue) on pH. The fitting of the experimental data yielded the 
following values: pKa1 =1.6 and pKa2 =3.9. 
By raising the pH above 4.5, the Soret band maximum shifts at 401 nm 
(ε ~ 9.8*104), the Q band move at 524 and 557 nm (ε ~ 6.2 *103 and 4.2 
*10
3
, respectively) and CT band at 618 nm disappears. This observation is 
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indicative of transition from a predominantly high-spin ferric state to a 
predominantly low-spin ferric state, typical of a bis-His coordination 
(characterized by a strong ligand field on the iron porphyrin).  
Two midpoints are observed at pH 1.5 and 3.9. In the pH range 1.4- 
2.5 (see Fig. 50) the presence of an isosbestic point (Fig. 51) suggests that 
only two species are predominantly involved in the equilibrium.  In analogy 
with previously characterized Mimochrome analogues, we suggest the first 
pKa (pKa = 1.50) corresponds to the apparent protonation of the axially 
coordinated histidines (pKapp), as defined by Kennedy.
88
  
 
 
Fig. 51 UV-vis spectra of Fe(III)-Mimochrome VII in the   pH range 1.4 - 2.5. Arrows 
indicate changes at 401 and 388 nm from alkaline to acidic pH. An isosbestic point appears 
at 394 nm. 
 
The very low value of the His pKa, point out very strong coordination 
of the axial histidine residues to the iron, and may indicate a highly 
hydrophobic local environment. This is in agreement with the designed 
model, which shows two leucine residues (Leu
12 
on each chain) that forms 
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hydrophobic interactions with the porphyrin, surrounding the histidine 
residues and creating a highly hydrophobic local environment. 
The pKa2 of Fe(III)-Mimochrome VII is more difficult to interpret. 
Since no major change in spin state occurs during this equilibrium, we 
suggest this pKa2 does not correspond to changes in the first coordination 
shell of the heme iron. More reasonably, the observed modification of the 
electronic spectrum are related to protonation equilibrium involving amino 
acid in the second coordination shell (see Fig. 52). In particular, an aspartic 
residue (Asp
3
), that was predicted to form hydrogen bond with the 
coordinating histidine, is suggested to be responsible for this transition (3.65 
is the pKa for Aspartic acid side chain  in free amino acid ).
142
 
 
Fig. 52 Proposed equilibria and species involved in the pH tritation of Fe(III)-Mimochrome 
VII. 
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3.5. Co(III)-Mimochrome VII: NMR spectroscopy 
The diamagnetic cobalt complexes of Mimochrome VII was analyzed 
by Nuclear Magnetic Resonance. The NMR analysis was carried out in 
H2O/TFE 50/50 (v/v), Fig. 53 shows the 
1
HNMR spectrum of Co(III)-
Mimochrome VII complex. 
There are two set of resonances for the deuteroporphyrin protons  in 
≈1:3 ratio, suggesting the presence of two species in solution. We named 
compound 1 (c.1) the most abundant species, and compound 2 (c.2) the 
other one.  
Due to resonance overlaps, we were not able to solve the three 
dimensional structure of compound 2, c.2 and the complete structural 
characterization was performed only on  compound 1, c.1.  
 
 
Fig. 53. Co(III)-Mimochrome VII 1D 1H spectrum. 
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3.6. Co(III)-Mimochrome VII c.1: resonances 
assignment and analysis 
Resonances assignment was accomplished by 2D experiments 
(NOESY, TOCSY, DQF-COSY) using standard methodologies. All the 
peptide and deuteroporphyrin proton resonances were unambiguously 
assigned. The assignment of deuteroporphyrin resonances was easily 
performed following the NOE connectivities around the macrocycle: the 5H 
proton was directly identified, as it is the only it is the only porphyrin proton 
in dipolar contact with two methyl groups (3-CH3 and 7-CH). Thanks to 
dipolar connectivity with methyl 7-CH3 it was easy to identify the pyrrole 
8H resonance. This lead to immediate identification of the -meso proton at 
position 10H, and, for exclusion, of pyrrole proton 13H and of the -meso 
proton 5H. The -meso proton 20H was finally identified, as it shows strong 
dipolar connectivities with the propionic ,'-CH2 and ,'-CH2. In 
particular, it was possible to distinguish the resonances of the ’CH2 and 
,’CH2 protons of the propionic group at position 2 of the deuteroporphyrin 
ring from those of the propionic at position 18 (see Fig. 32 for 
deuteroporphyrin numbering). Dipolar contacts were observed between these 
protons and the amino acidic residues, providing unambiguous assignment of 
the two peptide chains. 
We observed two sets of resonances for the peptidic part, with severe 
overlap for some of the homologous residues belonging to the two different 
peptide chains. These overlaps are more marked in the N-terminal region 
(Thr
1
, Asn
2
, Asp
3
, Trp
4
). 
Lysine 9 is covalently bound to the deuteroporphyrin propionyl 
groups. As already observed for other Mimochrome analogues, side chain 
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protons of this residue are upfiled shifted respect their random coil values, 
due to the ring current effects.  
 Histidine side chain protons were unequivocally assigned. In the 
TOCSY experiment, the δ-CH signals at δ = -0.38 and -0.40 ppm are 
correlated to ε-CH imidazole protons at δ = 0.02 and 0.09 ppm, respectively. 
These last resonances are in strong dipolar contact with resonance at δ = 9.17 
and 9.11 ppm, which were assigned to the imidazole δ-NH of the two 
histidines. The imidazole Nε atom is unprotonated and axially coordinate the 
Co(III) ion.  
Imidazole δ-CH and ε-CH protons have different connectivities with 
the deuteroporphyrin protons, thus indicating that the two histidines are 
characterized by different orientation with respect to the porphyrin plane. 
One imidazole ring presumably lies in a plane that is orthogonal to the 
deuteroporphyrin plane and oriented almost parallel to the N21-N23 direction, 
while the other imidazole plane is almost parallel to the N22-N24 direction 
(Fig. 54). 
 
Fig. 54 Histidine axial ligands orientation in Co(III)-Mimochrome VII compound 1. 
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Table 7 Dipolar connectivities between histidine imidazole protons and 
deuteroporphyrin IX protons 
Histidine (p.2) DPI X Histidine (p.18) DPI X 
Hδ2 20 H Hδ2 20 H 
 5H  15 H 
 3-CH3  13 H 
 /’CH2  17- CH3 
 /’-CH2  /’CH2 
   /’-CH2 
Hε1 10 H Hε1 10 H 
 15 H  8 H 
 13 H  7- CH3 
 
Both peptide chains showed a very similar pattern of NOE interactions, 
which strongly support the presence of a well organized structure. A right-
handed helical conformation could be inferred from Pro
6
 to Leu
16
 on the 
basis of the characteristic short-range NHi-NHi+1, CHi-NHi+1,CHi-NHi+1, 
and medium-range CH i-CHi+3,  CHi-NHi+3, CHi-NHi+4.  A non-regular 
structure occurs at N-terminal end (residues 1-5), which displays only few of 
the connectivities expected for a helical conformation. The CH chemical 
shifts were additional indicators of helical structure (Fig. 51). All residues 
and particularly His
8
, showed CH resonances significantly up-field shifted, 
relative to their random coil values (Fig. 55). Since this trend was observed 
also for the N-terminal residues, it is reasonable to assume that these 
deviations are due not only to peptide secondary structure but also to the 
deuteroporphyrin ring current effect.  
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Fig. 55 chemical shift index Δδ(-CH) (δosb - δ randomcoil) of compound 1. 
 
3.7. Co(III)-Mimochrome VII c. 1:solution structure 
from NMR data 
The solution structure of Co(III)-Mimochrome VII c.1 was solved by 
using CYANA software,
135
 on the base of 554 dipolar connectivities (Fig. 
56). Typical CYANA runs were performed and the 20 best structures are 
tightly clustered.  
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Fig. 56 summary of NOE contacts typical of secondary structure in Co(III)- Mimochrome 
VII spectrum. Each contact is represented by an horizontal line which connects the involved 
residues. The lines thickness represents the contacts intensity. 
Analysis of the ensemble of the structures by PROCHECK-NMR
136
 
revealed that 75.2% of backbone angles fall within the most favored regions 
of Ramachandran plot, 23.2% in additional allowed regions and 1.6% in the 
generously allowed  regions. 
Superposition of the best 20 structures on the mean coordinates gave, 
for Co(III)-Mimochrome VII c.1, an average root mean square deviation 
(rmsd) of 0.77 ±0.15 Å for all backbone atoms and 1.19 ±0.12 Å for all 
heavy atoms.  
 
 
 
 
 
 
 
 
Table 8 NMR statistics of the Co(III)-Mimochrome VII  20 
best NMR structures. 
Rmsd to averaged coordinates Å 
backbone 0.77 ± 0.15 
all heavy 1.19 ± 0.12 
target function (Å2) 0.65 ±5·10-2 
Ramachandran plot (%) 
most favored regions 74.2 
additionally allowed regions 22.6 
generously allowed regions 3.2 
disallowed regions 0.0 
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The two peptide chains in Co(III)-Mimochrome VII adopt right-
handed helical conformation from Pro
6
 to Leu
16 
(see Fig. 41 for residue 
numbering), while a less regular conformation is observed in the N-terminal 
region (Fig. 57). As designed, the global structure is stabilized by the 
presence of interactions between hydrophobic side chains and the 
deuteroporphyrin ring. In particular, Leu
12 
and Trp
4
 residues are facing the 
deuteroporphyrin plane, and they form hydrophobic interactions with the 
macrocycle. The side chains of hydrophilic residues (Glu
10
, Glu
13
, Lys
14
, 
Lys
17
) are solvent exposed.  
 
Fig. 57 Co(III)-Mimochrome VII three dimensional NMR structure, represented as a bundle 
of twenty structure. 
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3.8. Co(III)-Mimochrome VII compound 2: preliminary 
resonances analysis 
We also analyzed Co(III)-Mimochrome VII c.2. Unfortunately, due 
to severe resonance overlaps with compounds 1, we were not able to solve 
the NMR structure of this species. 
However, the qualitatively analysis of dipolar contacts together with 
the CH chemical shift (up-field shifted) suggested the presence of a helical 
conformation in the 6-17 region (see Fig. 58 ). 
 
Fig. 58 chemical shift index Δδ(-CH) (δosb - δ randomcoil) of compound 2 
The most noticeable difference between the two compounds is the 
orientation of the histidine rings with respect to the heme plane, as indicated 
by the different connectivities exhibited by imidazole δ-CH and ε-CH 
protons with respect to the deuteroporphyrin protons. A comparision of the 
imidazole orientation o in compound 1 and compound 2, as deduced from 
NOE connectivities, is schematically reported in Fig. 59.  
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Fig. 59: different orientation of imidazole rings in compound 1 and compound 2. 
Different orientation of the imidazole rings with respect to the 
porphyrin are indicative of a different topological form, since the orientation 
of the histidine side chain is a key factor in determining the orientation of the 
peptide chain with respect to the porphyrin plane.  
 
3.9. Design of a new model with improved peroxidase 
like activity: Mimochrome VII asym. 
The structural information obtained on Co(III)-Mimochrome VII were 
very useful in order to re-design a new model with peroxidase-like activity, 
which couple a well defined three dimensional structure with high catalytic 
performances. Therefore, the NMR structure of Mimochrome VII was used 
as a template to design a new complexes with an asymmetrical active sites 
(Fig. 60).  
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Fig. 60 Molecular model of Fe(III)-Mimochrome VII asym. 
This new model is characterized by the engineering into 
Mimochrome VII of a distal cavity, mimicking the HRP distal pocket. This 
cavity contains an arginine residue (Arg
12
), mimicking Arg
38
 of Horseradish 
Peroxidase (HRP), and a non-coordinating His residue (His
9
)  to mimic His
42
 
of HRP (Fig. 61).  
 
 
Fig. 61 Fe(III)-Mimochrome VII asym. sequence. The metalloporphyrin moiety is depicted 
as a black line. Below each amino acid, helix propensity according to Pace and Scholtz is 
reported.121 
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4. Artificial heme-proteins: determination of axial ligand 
orientations through paramagnetic NMR shifts 
To date, several heme protein models in the Mimochromes family have 
been developed, and some of these models have been extensively 
characterized. However, so far, structural data on Mimochrome active site 
geometry were obtained through the characterization of the diamagnetic 
Co(III) complexes. A paramagnetic ion modifies the properties of the 
nuclear spins coupled to it, and dramatically alters the NMR spectra. The 
coupling can occur through both chemical bonds and space, affects chemical 
shifts and relaxation rates. Specifically, the relaxation rates increase due to 
coupling with unpaired electron(s), and this phenomenon induces, in a 
distance-dependent manner, line broadening of vicinal nuclear spins, even 
beyond signal detection.
143,144
 Nevertheless, the paramagnetic effects are an 
important source of structural information, as they provide distance and 
geometric details about the environmentof the paramagnetic center in 
metalloproteins.  
In order to get information about the orientation of the axial ligands, 
the NMR characterization of  Mimochrome IV iron(III) paramagnetic 
complex was performed. In particular, by combining an empirical equation, 
proposed for bis-histidine ferriheme-proteins, with experimental data 
obtained for Fe(III)–mimochrome IV, we obtained information about 
histidine orientations.
145,146
  
In its essence, this methodology take advantage of the understanding of the 
relationship between the electronic structure of the heme, inferred by the 
paramagnetic shifts of its nuclei, and the orientation of the axial ligand(s). 
The heme of the low-spin hemeproteins has been characterized extensively, 
and semi-empirical and empirical equations have been developed to correlate 
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the hyperfine shifts of the heme-methyl resonances with the orientation of 
the iron axial ligand(s).
147-153 
With the aim to extend these methods to peptide-based artificial 
metalloproteins, and to fully characterize the active site structures of 
mimochromes, during this PhD research project, in collaboration with the 
Inorganic Biochemistry and NMR group of the Instituto de Tecnologia 
Química e Biológica of Lisbona, the empirical equation proposed by Turner 
was applied to Fe(III)-Mimochrome IV complex.
145
 
Within the family of Mimochromes, Mimochrome IV is a simple, 
structurally defined heme-protein model, with two histidine residues which 
act as axial ligands to the metal ion, that was completely characterized. In 
particular, the three-dimensional structure of its Co(III) complex was 
determined by NMR spectroscopy and X-ray diffraction. The solution and 
solid state structures  share numerous features and conform well to the 
design, adopting the designed sandwich structure, with the ∆ configuration 
of the Co(III) ion, and have been used as framework for the engineering of 
new models with improved properties, in this and other works. Due to its 
simple and well defined structure, Mimochrome IV molecule can be a useful 
tool for exploring the delicate mechanisms that control the heme functions, 
such as redox potential. Indeed, the heme redox potential of Mimochrome IV 
falls within the range observed for natural cytochromes, which present a bis-
His coordination, making this model may be a valuable system in the 
development of electrochemical biosensors.  The ability to use Mimochrome 
IV and its analogues in biosensor technology has been explored in different 
works, that are aimed at use these artificial molecules as bio-recognition 
elements/signal transducers for biosensing. 
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Therefore, we undertook the NMR analysis of Fe(III)-Mimochrome 
IV. A preliminary analysis was carried out in aqueous solution (phosphate 
buffer 10 mM, pH = 6.5). Although broad resonances were observed, four 
signals (at 21.5 ppm, 19.9 ppm, 14.5 ppm and 10.7 ppm) could be 
reasonably assigned to the heme methyl protons. The spread of these 
resonances is 10.8 ppm, still indicative of a preferred orientation of axial 
ligands (~5 ppm is the spread observed for freely rotating axial ligands) (Fig. 
62). 
 
Fig 62. Fe(III)-Mimochrome IV 1D 1H spectrum in phosphate buffer (10 mM, pH 6.5). 
 
However, in order to improve the NMR spectral quality, the analysis 
was performed in phosphate buffer (10 mM, pH 6.5)/TFE/DMSO solution 
(60/20/20, v/v/v). In particular, TFE is a well-known helix-inducing solvent, 
and the addition of a small amount of TFE to the Fe(III)–Mimochrome IV 
solution resulted in an increase of the helical content. The folding induced by 
TFE causes the two helical peptides to enwrap the heme faces, thus 
positioning the imidazole rings appropriately with respect to the porphyrin 
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ring. The correct folding in the mixed water–TFE solvent is relevant for 
catalytic Mimochromes. In fact, the presence of an organic co-solvent does 
not inactivate this class of artificial enzymes, as usually observed for natural 
enzymes. This finding is very significant for the catalysis of substrates with 
limited aqueous solubility. Also, the addition of DMSO, a high viscosity 
solvent (Z = 2 mPa s at T = 298 K), to an aqueous solution, increases the 
viscosity of the medium and modifies the relaxation rates, thus affecting the 
spectral lines. 
The 1D spectrum is typical of low-spin S = ½ bis-His ferriheme-
proteins. It shows several signals shifted out of the diamagnetic region, as a 
consequence of the effect of the paramagnetic iron (III) ion. In particular, 
four resonances in the region spanning from 5 to 30 ppm can be attributed to 
the heme methyl groups (Fig. 63). The methyl prtons have a mean shift of 
18.5 ppm and a spread of ca. 20 ppm, indicative of fixed orientation of the 
heme axial ligands. This is typical of heme-proteins, in which the axial 
ligands are held in fixed orientation by interaction with the protein matrix. 
On the contrary, small heme protein models usually have axial ligands that 
rotate very rapidly (on the order of hundreds of thousands to a million times 
per second), and an average hyperfine shift is detected for each heme 
substituent.
154,155
 In Mimochrome IV, the presence of the peptide chains 
constrains the histidines to be uniquely oriented. 
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Fig. 63 Fe(III)-Mimochrome IV 1D 1H spectrum. 
 
The assignment of the proton methyl resonances was performed 
starting from the 5-meso proton at -1.06 ppm, since is the only proton in 
dipolar contact with the two methyl groups, 7-CH3 and 3-CH3 at 26.1 ppm 
and 16.9 ppm, respectively. The methyl resonance at 24.5 ppm exhibits 
dipolar connectivities to a signal at -0.77 (15-meso) and to two protons at 
about 3 ppm (reasonably attributed to the propionic methylene protons), and 
therefore it was attributed to the methyl groups at position 17. Finally, the 
resonance at 6.67 was attributed to methyl at position 12 (Fig. 64). 
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Fig. 64 Fe(III)-Mimochrome IV details of the NOESY spectrum. 
 
In order to determine the axial ligand orientations of Fe(III)–
Mimochrome IV, the methyl chemical shifts measured at 298 K were 
introduced into the empirical equation proposed by Turner: 
 
δi(ppm) = cosβ[38.0 sin
2(θi-)-4.1 cos
2(θi +)-15.9]+13.8            Eq. (1) 
 
where δi is the hyperfine shift of the ith methyl, θi is the angle between the 
metal-ith methyl direction and the metal-N23 nitrogen axis,  is the acute 
angle between the two histidine planes, and  is the angle between the 
bisector of the angle  and the metal-N23 direction (see Fig. 65 for 
nomenclature). Eqn. (1) provided β and values of 51° and 34°, 
respectively. 
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Fig. 65 Schematic representation of the heme moiety. The reference axis is taken along the 
metal- N23 direction. The β angle defines the acute angle between the two histidine planes 
and the  angle defines the average orientation of the His planes, projected on the heme 
plane, with respect to the N21-N23 direction. 
A comparison between the experimental and calculated values of 
1
H 
methyl chemical shifts is schematically illustrated in Fig. 66, which shows 
the good agreement between the pattern of distribution of the experimental 
shifts and the theoretical fit. Table 9 reports the  and  values calculated for 
the Fe(III)–Mimochrome IV complex compared with those observed in the 
Co(III)–Mimochrome IV crystal and NMR structures. 
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Fig. 66 Diagram showing a) experimental and b) calculated chemical shifts of the heme 
methyls. Lines have the iron at the origin and are directed towards each substituent, with a 
length proportional to the shift. The implicit orientation of the heme is as represented in Fig. 
65. 
 
Table 9 Comparison of  and in Mimochrome IV complexes
   
Fe(III)- Mimochrome IV 51 3 
Co(III)- Mimochrome IV X-ray 57 47 
Co(III)- Mimochrome IV NMR 52 33 
 
The orientation of axial histidines  in Fe(III)–Mimochrome IV is 
nearly identical to that observed in the solution structure of its cobalt 
complex, with the imidazole planes nearly eclipsing the Np–Co– Np bonds. 
In contrast, the metal binding site shows a different geometry in solid state, 
where the histidine planes are almost perpendicular. These data highlight 
that the main issue in determining the histidine orientation in Mimochrome 
IV is the direction of the two helices with respect to the porphyrin plane, 
which, in the Co(III)– Mimochrome IV crystal is affected by crystal packing 
interactions.  
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5. Conclusions and Future perspectives. 
The design of metalloprotein models, tailored to specific applications, 
is emerging as an important topic in protein chemistry. To date, several 
groups have made significant progress toward the design of proteins with 
functions and activities similar to those of natural enzymes. Metalloprotein 
mimetics have been developed through the introduction of novel metal-
binding sites within the naturally occurring proteins as well as through de 
novo design. Such studies are stimulated by the ambition to shed light on the 
fundamental features for catalytic activity, and by the possibility to develop 
novel synthetic proteins for biotechnological applications. Tailoring 
synthetic models requires the development of sophisticated molecular 
architectures that distil the quintessential elements responsible for activities. 
Thus peptide-based metalloprotein models seem to be suitable candidates to 
mimic both the structural features and reactivity of the natural systems. 
This approach has been successfully applied to different natural 
proteins involved in biological electron transfer, catalysis and gene 
regulation. A protein family that has received considerable attention is the 
heme-protein family. Heme-proteins are involved in a wide range of 
biological processes, and over the years, a large number of peptide and 
protein-based heme-protein mimetics have been developed, in order to 
determine how the protein matrix tunes the properties of the heme to evoke 
the wide variety of activities.  
 
The aim of this PhD thesis was to engineer new heme-protein mimetics 
characterized by a well-defined three-dimensional structure, thus allowing 
structural characterization. In particular, the research activity was focused on 
the rational design, synthesis, and characterization of new Mimochrome 
Conclusions and perspectives: chapter 5 
110 
 
analogues. These molecules belong to a class of heme-proteins developed by 
the Artificial Metallo Enzyme Group of Naples.  
In this PhD project, two different strategies have been followed to 
take into account all the variables necessary to specify both the structure and 
the function in the Mimochrome family of molecules. In particular, new 
mimetics have been designed by:  
 
 incorporation of non-coded amino acid with -helix stabilizing effect 
into the Mimochrome VI structure; 
 elongation of the peptide chains, that allows the introduction of a 
large number of intra-chain and inter-chain interactions. 
 
Both strategies afforded to the design and synthesis of two new 
molecules, named Mimochrome VI-2U1L and Mimochrome VII.  
 
During the research activity, the important goal of the structural 
characterization of the Co(III)- complexes of these analogues was reached. 
The information derived on Mimochrome VI-2U1L structures will be used to 
obtain a detailed structure-activity relationship analysis on Mimochrome VI 
and its analogues. In addition, the availability of the solution structure of 
Mimochrome VII should allow to engineer new molecules. Indeed, in this 
thesis the design of an asymmetrical penta-coordinated model, Mimochrome 
VII asym derivative, characterized by a distal cavity that contains an arginine 
residue, mimicking Arg
38
 of Horseradish Peroxidase (HRP), and a non-
coordinating His residue to mimic His
42
 of HRP was done, and its 
characterization is now under course.  
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With the aim to fully characterize the active site structures of 
Mimochromes, another important results of this thesis work is the NMR 
characterization of the paramagnetic peptide-based hemeprotein mimetics, 
Fe(III)–Mimochrome IV complex. By combining an empirical equation, 
proposed for bis histidine ferriheme-proteins, with experimental data 
obtained for Fe(III)–Mimochrome IV, information about histidine 
orientations were obtained. In summary, it has been shown that it is possible 
to determine the histidine orientations in artificial peptide-based heme-
protein models by taking advantage of a methodology previously used for 
natural ferriheme-proteins.  
 
The results herein reported highlight that in small models, which lack 
the complex architecture of the natural protein, the carefully engineering of 
numerous and diverse interactions, such as hydrophobic, ion-pair and 
coordination interactions, is crucial for the development of molecules with 
unique structures and functions. In addition, an important result of this thesis 
has been the successfully application of an empirical equation, describing the 
relationship between the porphyrin methyl hyperfine shifts and the position 
of the axial ligand(s), to these artificial heme-protein.  
 
In conclusion, the different design strategies and experimental 
methodologies reported in this work will in future allows to perform iterative 
process of redesign and characterization, with the final goal of obtaining 
functionally active molecules with a well defined structure. 
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6. Mimochrome VI-2U1L 
 
6.1.  General 
All 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids, Nova 
Syn TG Sieber resin and coupling reagents: N-hydroxybenzotriazole 
(HOBt), O-7-Azabenzotriazol-1-yl-N,N,N’,N’’-tetramethyluronium 
hexafluorophosphate (HATU) and benzotriazole-1-oxy-tris-pyrrolidino-
phosphonium hexafluorophosphate (PyBOP) were purchased from 
NovaBiochem (EMD Biosciences, La Jolla, CA). Silica gel 60 (230-400 
mesh) was from Merck. Precoated silica G-60 plates, F254, were used for 
thin-layer chromatography (tlc). All solvents used in the peptide synthesis 
and purification were anhydrous and HPLC grade respectively, and were 
supplied by Romil. Piperidine and scavengers (ethanedithiol, 
triisopropylsilane) were from Fluka. N,N-Diisopropylethylamine (DIEA), 
trifluoroacetic acid (TFA) were supplied from Applied Biosystems. N,N-
dimethylformamide (DMF), dichloromethane (DCM), pyridine, ethanol, 
methanol and 1-methyl-2-pyrrolidone (NMP) were supplied by Romil. 
Deuteroporphyrin IX was from Porphyrin Products. Cobalt(II) acetate was 
purchased from Sigma Aldrich. Solvent mixtures are indicated in the 
respective sections. 
The structures were generated with Visual Molecular Dynamics (VMD; 
http://www.ks.uiuc.edu/Research/vmd/)
156
 and Accelrys Discovery Studio 
3.0 (http://accelrys.com/).157 
 
6.2. Synthetic strategy 
Mimochrome VI-2U1L was prepared similarly to other 
Mimochromes.
118
 The two peptide chains were synthesized by the solid-
phase method using the 9-fluorenylmethoxycarbonyl (Fmoc) protection 
Experimental part: chapter 6 
114 
 
strategy. After selective deprotection of Lys
9
 residue on the two chains, the 
peptides were cleaved from the resin, without removing the other side chain 
protecting groups (Fig.67). They were then coupled to deuteroporphyrin IX 
in solution to afford, after side chain deprotection, Mimochrome VI-2U1L. 
 
6.2.1. Peptides synthesis 
Mimochrome VI-2U1L decapeptide and Mimochrome VI-2U1L 
tetradecapeptide were synthesized using Fmoc (9- 
fluorenylmethoxycarbonyl) solid phase peptide synthesis (SPPS) on an ABI 
433 automatic peptide synthesizer on a 
0.2 mmol scale. The resin used for the 
peptides was the super acid labile Nova 
Syn TG Sieber (substitution level 0.2 
mmol/g) (Fig. 64).  
For all the peptides the same 
synthetic procedures were used. The 
first step was the synthesis of the fully 
protected peptides. The synthetic procedure can be summarized as follow. 
The α- Fmoc group, was removed at the beginning of every cycle with a 
20% piperidine solution. After deprotection, the resin was washed with NMP 
to remove the piperidine. The peptide resin was then ready for coupling. All 
amino acids were coupled using a 0.45 M HBTU/HOBT solution in DMF. In 
the coupling step, the activated Fmoc amino acid reacts with the amino-
terminal group of the growing peptide chain to form a peptide bond. 
Deprotection and coupling steps were repeated with each subsequent 
amino acid, until the chain assembly was completed. When the coupling was 
Fig. 67 Nova Syn TG Sieber resin 
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complete, the resin was washed with NMP. Peptides N-terminal amino 
groups were acetylated with acid acetic (1mmol, 57 μl).  
For the synthesis of the two peptides the following amino acids were used: 
Mimochrome VI-2U1L decapeptide: Fmoc-Asp(OtBu)-OH; Fmoc-
Glu(OtBu)-OH; Fmoc-Gln(Trt)-OH;Fmoc-Aib-OH; Fmoc-Leu-OH; Fmoc-
Ser(tBu)-OH; Fmoc-Lys(Mmt)-OH; Fmoc-Arg (Pbf)-OH. 
  
Mimochrome VI-2U1L tetradecapeptide: Fmoc-Asp(OtBu)-OH; Fmoc-
Gln(Trt)-OH; Fmoc-Leu-OH; Fmoc-His(Trt)-OH; Fmoc-Ser(tBu)-OH; 
Fmoc-Lys(Mmt)-OH; Fmoc-Arg(Pbf)-OH; Fmoc-Lys(Boc)-OH; Fmoc-Ile-
OH; Thr(tBu)-OH. 
6.2.2. Mmt deprotection and cleavage of 
Mimochromes peptides 
Fully protected peptides amide, except for the Lys
9
, were generated 
from the resin separately, following the same protocol. (Fig. 66) The 
protecting group on N-ε function of the Lys9 was chosen such as since its 
cleavage conditions were  different than those used for the other side chain 
protecting groups. Specifically, The Mmt protecting group was used, since it 
can be easily removed by repeated treatments with a solution containing 
10% acetic acid and 20% trifluoroethanol (TFE) (v/v) in CH2Cl2, without 
affecting the other protecting groups. This treatments was performed at the 
end of the synthesis, when the peptide is still linked to the resin and was 
repeated until no yellow or red trityl cations were detected in the eluent. 
After this step, cleavage of the peptides from the  resin was achieved 
with a solution 1%TFA in DCM. 3-4 resin volumes of a freshly prepared 
cleavage mixture (1%TFA in DCM, 20 ml) were added. The acidic mixture 
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was incubated for 2 minutes, under mixing. The solution was filtered with a 
vacuum pump, into an ice-cold flask containing 2 ml of 10% 
pyridine/methanol (v/v). 
The reaction was followed by TLC (Thin Layer Chromatography,  
chloroform/methanol/acetic acid 80:18:2); each step was repeated until no 
product was detected in the collected fractions. The fractions containing the 
product were combined and evaporated under reduced pressure up to 5% of 
the volume. Ice-cold water was added to the residue and the mixture was 
cooled on ice to aid precipitation of the protected peptides. The product was 
filtered, washed several times with fresh water, and dried under vacuum to 
give the crude C-terminal peptides amide. Both peptides were homogeneous 
as determined by analytical HPLC and by ESI –MS. 
 
 
 
Fig. 68 Protocol of Mmt deprotection and cleavage from the resin. 
 
6.2.3. Synthesis of the monosubstituted intermediate 
decapeptide-deuteroporphyrin IX. 
A suitable procedure for the coupling reaction between the 
decapeptide and the deuteroporphyrin IX  was adopted, to avoid the 
formation of the disubstituted intermediate. In particular, the decapeptide 
solution ( 419 mg, 0.20 mM , M.W. = 2119.6) was slowly added to the 
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solution containing deuteroporphyrin IX (1.5 eq., 0.30 mol, 173 mg) and 
HATU (activating reagent, 1eq., 75.1 mg). the pH was adjusted with DIEA, 
7 eq. (pH ≈ 8.0). In this way, the porphyrin was never in the presence of 
peptide excess, thus favoring monosubstitution. The reaction mixture was 
stirred for 2 h at room temperature, and the outcome was followed by 
analytical TLC, solvent system chloroform/methanol 90/10. 
The crude product was purified by Flash Chromatography using a 
Biotage Isoelera flash purification system, equipped with a diode-array 
detector, on SNAP HP 100 g silica column (5 x 30cm), using a 
chloroform/methanol gradient from 0 to 15% methanol. The desired 
protected monoadduct was separated from the porphyrin and the un-reacted 
peptide, and analyzed by RP-HPLC, on a C-8 column, using a linear gradient 
elution of water/acetonitrile 0.1% TFA. The chromatographic profile, shown 
in figure , evidences two peaks of similar intensity at 45.7 and 46.7 minutes 
(Fig. 69).  
The ESI-MS analysis of the two peaks reveals the same mass spectra, 
and in both mass spectra in addition to the main peak of 1307.35, 
corresponding to the ion [M-2H]
2+/
2 is observed.  Attempt to separate the 
two peaks through Flash Chromatography were not successful, due to their 
similar Rf. 
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Fig. 69 HPLC chromatogram and ESI-MS spectrum of monosubstituted intermediate 
decapeptide-deuteroporphyrin IX. 
 
 
6.2.4. Synthesis of disubstituted intermediate 
decapeptide-DPIX-tetradecapeptide 
The Mimochrome VI-2U1L apo form was synthesized by coupling the 
tetradecapeptide (573 mg, 0.18 mmol, P.M. = 3239 mg/mmol with the 
monosubstituted decapeptide-deuteroporphyrin IX intermediate (357 mg, 
0.14 mol, P.M. = 2612mg/mmol). A small excess of tetradecapeptide was 
used, to drive the reaction to completion.  
The outcome of the reaction was followed by analytical TLC. 
Subsequently, the desired product was separated from the monosubstituted 
intermediate and the un-reacted tetradecapeptide  by Flash Chromatography 
using a linear gradient elution of CHCl3/CH3OH. 
The protected apo form was than deprotected using a cleavage mixture 
of 94% TFA, 2.5% EDT, 1% TIS, 2.5% H2O v/v/v/v; 10 ml. The reaction 
was conducted at 273 K for 1h and at room temperature for the second hour, 
with stirring; the final mixture was concentrated on a rotary evaporator to a 
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volume of approximately 1-2 mL. Extraction of the scavengers and 
precipitation of the crude product was achieved by addition of cold diethyl 
ether. The mixture was centrifuged, the supernatant was removed and the 
precipitate was washed twice with three volumes of cold diethyl ether. The 
mixture was dried to remove diethyl ether, redissolved in water 0.1 % TFA 
and analyzed by LC-MS (Vydac C-18 column, using a gradient of 
acetonitrile in 0.1% aqueous TFA, 5 % to 80% over 35 min). The crude 
material was then purified by preparative RP-HPLC (Vydac 2.2 cm C18 
column at 22 mL min-1, using a gradient of acetonitrile in 0.1% aqueous 
TFA, 10% to 80% over 58.4 min); the pooled fractions containing the 
desired product were lyophilized. The chromatogram showed the presence of 
two peaks that have same area, slightly different retention times and the 
same mass spectrum.  
6.2.5. Cobalt insertion 
Cobalt ion was inserted into Mimochrome VI-2U1L apo form  (13 mg, 
3.8 * 10
-3
 mmol) according to literature procedure.
45
 Co(II) acetate (10 molar 
excess) was added to a solution of pure Mimochrome VI-2U1L apo form in 
2/3 TFE/AcOH (v/v) (19 mL, final concentration, 2.0*10
-4
 M), and the 
reaction mixture was kept at 348K for 2 h, refluxing under nitrogen. The 
reaction was monitored by analytical HPLC. The solvent was then removed 
under vacuum, and the product was purified to by preparative RP-HPLC.  
 
6.3. NMR spectroscopy 
6.3.1. NMR data collection 
Samples for NMR spectroscopy were prepared using by dissolving 
weighted amounts of Co(III)-Mimochrome VI-2U1L in H2O/ TFE 60/40 
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(v/v) V = 0.600 ml). The final concentrations of the samples were between 2 
*10 
-4
 M and 5 *10
-4
.  
All NMR spectra were acquired at at 298 K on a Bruker Avance 600 
spectrometer equipped with a triple resonance cryo-probe. Suppression of 
the water signal was accomplished by excitation sculpting sequence. Two 
dimensional NOESY, TOCSY and DQF-COSY spectra were acquired at 
very high digital resolution, using standard pulse sequences. For peak a 
NOESY spectra were acquired using mixing time ranging from 200 ms and 
300 ms. Subsequently, 200 ms  mixing time was selected to acquire the 
NOESY spectra of all peak. TOCSY experiment was performed with spin 
lock applied for 70 ms.  
 
 
6.3.2. Resonances assignment and strcutural 
calculation 
NMR Spectra were processed using Bruker TOPSPIN software and 
analyzed with the CARA program. The 
1
H chemical shifts (in ppm) of 
Co(III)-Mimochrome VI-2U1L peak a and Co(III)-Mimochrome VI-2U1L 
are reported in table 10 and 11 for peak a and peak b respectively. 
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Table 10 Co(III)-Mimochrome VI-2U1L peak a assignment 
Tetradecapeptide 
Aa N-H  -H H- H- H-δ others 
ACE  1.99     
Asp1 7.82 4.59 2.81    
Leu2 8.16 3.33 
1.41 
0.53 
1.18 
0.91 
0.70 
 
Gln3 8.30 3.28 
1.88 
1.79 
2.07  
Hε1,2     7.13 
         6.49 
Gln4 7.86 3.68 
1.91 
1.90 
2.26 
2.21 
 
Hε1,2    7.20 
          6.53 
Leu5 7.61 3.55 
0.95 
0.50 
0.81 
0.62 
0.17 
 
His6 6.31 2.33 
1.50 
1.11 
 
Hδ1  9.23 
Hδ2 -0.49 
Hε1      -0.16 
Ser7 7.47 3.83 3.75    
Gln8 7.60 4.13 
2.12 
1.93 
2.29  
Hε1,2      7.02 
           6.59 
Lys9 7.35 3.98 1.68 1.53 1.44 
Hε,ε’      3.13 
            2.43 
Hζ       8.23 
Arg10 8.02 4.11 
1.85 
1.73 
1.55 
1.44 
3.14 
3.05 
Hε        7.05 
Lys11 7.82 4.13 
1.95 
1.93 
1.55 
1.42 
1.70 Hε,ε’        2.96 
Ile12 7.95 4.06 2.05 
Hγ12,13- CH2   1.71 
                      1.31 
Hγ2- CH3       1.05 
0.96  
Thr13 7.95 4.37 4.40 1.45   
Leu14 7.95 4.42 1.85 1.68 0.97  
NH2 
7.25, 
6.93 
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Decapeptide 
Aa H-N H- H- H- H-δ others 
ACE  2.01     
Asp1 8.02 4.62 
2.86 
2.81 
   
Glu2 8.33 3.99 
2.01 
1.97 
2.39   
Aib3 8.02  
1.41 
1.29 
   
Gln4 7.95 3.85 
1.97 
1.90 
2.33 
2.32 
 
Hε1,2    7.24 
          6.56 
Leu5 7.80 3.96 
1.64 
1.57 
1.39 
0.84 
0.77 
 
Ser6 7.59 3.85 3.60    
Aib7 7.58  
1.38 
1.28 
   
Glu8 7.68 3.88 
1.92 
1.85 
2.24   
Lys9 7.55 3.65 
1.43 
1.29 
0.97 
0.87 
0.96 
Hε,ε’   2.82 
Hζ       7.41 
Arg10 7.56 4.14 
1.91 
1.74 
1.64 
1.59 
3.15  Hε      7.13 
NH2 
7.08 
6.85 
     
 
Deuteroporphyrin IX 
2 -α,α’CH2 4.93, 4.39 8H 9.48 
18-α,α’CH2 4.96, 4.27 10 H 10.60 
2 -β,β’CH2 3.45, 3.02 12CH3 3.86 
18-β,β’CH2 3.14, 3.07 13 H 9.40 
3CH3 3.79 15 H 10.28 
5H 10.50 17CH3 3.68 
7 CH3 3.79 20 H 10.59 
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Table 11:  Co(III)-Mimochrome VI-2U1L peak b assignment  
Tetradecapeptide 
Aa H-N H-  H- H- H-δ others 
ACE  1.99     
Asp1 7.78 4.58 2.79    
Leu2 8.16 3.35 
1.43 
0.50 
1.24 
0.97 
0.70 
 
Gln3 8.30 3.28 
1.89 
1.80 
2.06   
Gln4 7.89 3.69 1.90 
2.26 
2.21 
  
Leu5 7.63 3.55 
1.04 
0.54 
0.82 
0.60 
0.05 
 
His6 6.35 2.32 
1.50 
1.13 
 
Hδ1 9.24 
Hδ2 -0.43 
Hε1 -0.174 
Ser7 7.50 3.81 3.74    
Gln8 7.68 4.07 
2.07 
1.95 
2.29   
Lys9 7.43 3.96 1.63 1.47 1.62 
Hε,ε’  3.15 
        2.30 
Hζ     8.39 
Arg10 8.03 4.05 
1.83 
1.72 
1.50 
3.12 
2.99 
Hε  6.99 
Lys11 7.80 4.09 1.95 
1.55 
1.41 
1.67 Hε,ε’ 2.94 
Ile12 7.97 4.04 2.05 
Hγ12,13- CH2   
1.71 
                       
1.30 
Hγ2- CH3       
1.04 
0.94  
Thr13 7.95 4.34 4.41 1.46   
Leu14 7.97 4.42 1.86 1.68 0.97  
NH2       
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Decapeptide 
Aa H-N H- H- H- H-δ others 
ACE  2.02     
Asp1 8.00 4.63 
2.86 
2.81 
   
Glu2 8.35 3.99 
2.03 
1.99 
2.39   
Aib3 8.03  
1.42 
1.32 
   
Gln4 7.95 3.83 1.97 2.31  - 
Leu5 7.81 3.96 1.41 1.65 
0.85 
079 
 
Ser6 7.61 3.84 3.64    
Aib7 7.55  
1.38 
1.25 
   
Glu8 7.67 3.87 1.85 2.23   
Lys9 7.52 3.53 1.40 1.23 0.85 Hε,ε’ 2.80 
Arg10 7.50 4.12 
1.91 
1.73 
1.62 3.15 Hε     7.13 
NH2       
 
Deuteroporphyrin IX 
2 -α,α’CH2 4.95, 4.28 8H 9.54 
18-α,α’CH2 4.95,  4.41 10 H 10.63 
2 -β,β’CH2 3.14, 3.05 12CH3 3.86 
18-β,β’CH2 3.46, 3.01 13 H 9.40 
3CH3 3.71 15 H 10.42 
5H 10.45 17CH3 3.72 
7 CH3 3.82 20 H 10.60 
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Intensities of dipolar connectivities in the two-dimensional NOESY 
spectrum, obtained using a 200 ms mixing time, were measured using the 
integration subroutine of the CARA program. Peak volumes were converted 
into upper limit of inter-atomic distances, to be used as input for structural 
calculation. 
 A total of 395 and 341 NOESY cross peaks was assigned, integrated 
and transformed in upper distance limits with the program CALIBA,
158
 for 
peak a and peak b, respectively. Of these NOE upper distance limits, 142 for 
peak a and 121 for peak b were removed, because they do not effectively 
restrict the conformation. In conclusion, we obtain two set of 253 (196 intra-
chain distances and 57 distances involving and 255 upper distance limit 
restraints that were used as input for structural calculation. 
In order to perform the simulated annealing, two non standard residue 
were added to the CYANA standard library: a residue containing Co(III)-
deuteroporphyrin IX, that is anchored to the peptide chain through the use of 
special linker residues (as described in CYANA tutorial) and a modified 
lysine residue, which has only one  proton on the side chain N
ζ
 atom, since 
this atom is involved in formation of amidic bond with one of the 
deuteroporphyrin propionyl group.  
Additional restraints were added to simulate the histidine coordination, 
and the amide bond formation between the lysine side chain and the 
deuterporphyrin. The quality of the obtained structures was evaluated in 
terms of deviations from ideal lengths and bond angles through a 
Ramachandran plot obtained using the program PROCHECK-NMR. 
Experimental part: chapter 7 
126 
 
 
7. Mimochrome VII 
 
7.1. Synthetic strategy 
Mimochrome VII was prepared similarly to Co(III)-Mimochrome VI-
2U1L; the peptides were synthesized by the solid-phase method using the 9-
fluorenylmethoxycarbonyl (Fmoc) protection strategy. The resin used for the 
was Nova Syn TG Sieber (9-fmoc-amino-xanthen-3-yloxy TG resin, 
substitution level 0.2 mmol/g). For the synthesis of the peptide the following 
amino acids were used: 
 
Ac-Thr
1
(tBu)-Asn
2
(Trt)-Asp
3
(tBuO)-Trp
4
(Boc)-Asp
5
(tBuO)-Pro
6
-
Thr
7
(tBu)-His
8
(Trt)-Gln
9
(Trt)-Glu
10
(tBuO)-Lys
11
(Mmt)-Leu
12
-
Glu
13
(tBuO)-Lys
14
(Boc)-Arg
15
(Pbf)-Leu
16
-Lys
17
(Boc)-NH2  
 
After selective deprotection of Lys
11
 residue, the peptid was 
cleaved from the resin, without removing the other side chain 
protecting groups. There were then coupled to deuteroporphyrin IX 
in solution to afford, after side chain deprotection, Mimochrome 
VII apo form.
 
 
7.1.1. Synthesis of the deuteroporphyrin mono-
substituted derivative 
The first step was the deuteroporphyrin activation: 
 the deuteroporphyrin IX dihydrochloride (44 mg, 0.075 mmol, M.W. 
583.5 g/mol) was dissolved in 1 mL DMF and 43.5 μL DIEA (5 eq., 
0.250 mmol, M.W., 129.24 g/mol; density, 0.742 g/mL).  
Experimental part: chapter 7 
127 
 
 1 equivalents of HATU (19 mg, M.W., 380.23 g/mol) was dissolved 
in 500 μL DMF, and added to the deuteroporphyrin.  
Subsequently, the eptapeptide (190 mg, 0.0500 mmol) was dissolved 
in 1 mL DMF and DIEA 17.e μL ( 2 eq.). The peptide solution was then 
added dropwise to the deuteroporphyrin solution. 
The pH was adjusted with DIEA (pH ≈8.0). the reaction mixture was 
stirred at room temperature, and monitored by tlc (solvent system 
chloroform/methanol 90:10). After one hour and a half, the reaction mixture 
was evaporated under reduced pressure and dried. The crude product was 
purified on a silica gel column (30 g, 230–400 Mesh, 3.5 x 60 cm), with 
stepwise elution using a chloroform/methanol gradient from 0 to 10% 
methanol. The product was eluted at 10% methanol, evaporated under 
reduced pressure and dried. 
 
7.1.2. Synthesis of the apo form 
The monopeptide adduct (80 mg, 0.019 mmol) was dissolved in 1 mL 
of DMF. HATU (8.6 mg, 0.023 mmol) was dissolved in 200 μL of DMF and 
added to the monopeptide solution. 6 eq. (19.8 μL) of DIEA were added. 
The eptapeptide was dissolved in 900 μL of DMF. This solution was 
then added to the monopeptide adduct solution and the reaction was allowed 
to proceed at room temperature for hour and a half and the pH was checked 
during the reaction time.  The reaction was monitored by tlc (solvent system 
chloroform/methanol 90:10). After one hour and a half the reaction mixture 
was evaporated under reduced pressure. The product was dissolved in 
chloroform, and extracted six times with water, and evaporated again. 
Side chain deprotection was achieved by addition of the cleavage 
mixture (thioanisole/H2O/EDT/TFA 0.25/0.5/0.5/8.75, v/v/v/v) (1,2-
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ethanedithiol: EDT) at 273 K for 2.5 h. The reaction mixture was 
concentrated on a rotary evaporator to a volume of approximately 1-2 mL. 
Extraction of the scavengers and precipitation of the crude product was 
achieved by addition of cold diethylether. After six washing with 
diethylether, the crude material was then dried in vacuo and analyzed by  
RP-HPLC (Vydac C18 column, using a H2O 0.1% trifluoroacetic acid (TFA) 
(v/v) (solvent A) and acetonitrile 0.1% TFA (solvent B) linear gradient, from 
5% to 70% (solvent B) over 60 min, flow rate 0.5 mL min
-1
). ESI-MS 
confirmed the expected molecular weight 4833.3 amu) for the most abundant 
product (Fig 70). 
 
 
Fig. 70 HPLC chromatogram and ESI-MS spectrum of symmetric  Mimochrome VII apo 
form. 
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7.1.3. Iron insertion 
Iron was inserted into Mimochrome VII symmetric according to the acetate 
method.
45
 
Iron (II) acetate (10 molar excess), was added to a solution of pure free base 
in TFE/Acetic acid (6/4 v/v), and the reaction mixture was kept at ≈ 358 K 
for 1 h, refluxing under nitrogen. After 20 minutes, the reaction mixture 
started to turn slowly brown. After 1h,  the HPLC chromatogram showed the 
presence of a new peak with the characteristic UV-visible spectrum of the 
iron (III) deuterophorphyrins at acidic pH, λmax = 388 nm The product was 
then purified by preparative RP-HPLC, and the LC-MS IT-TOF (ion trap 
(IT) and time-of-flight (TOF) mass spectrometry) analysis of the pure 
product confirmed the identity of the desired compounds (expected 
molecular weight 4887.2 amu ) (Fig. 71). 
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Fig. 71 HPLC chromatogram (a) and LC-MS IT-TOF (b)  spectrum of  Fe(III)- 
Mimochrome VII. 
 
7.1.4. Cobalt insertion 
Cobalt was inserted into Mimochrome VII according to the acetate method.
45
 
Co(II) acetate (10 molar excess) was added to a solution of pure free base in 
TFE/Acetic acid (6/4 v/v), and the reaction mixture was kept at 348 K for 1 
h, refluxing under nitrogen. After 20 minutes, the reaction mixture started to 
turn slowly brown. After 1h,  the HPLC chromatogram showed the presence 
of a new peak  with the characteristic UV-visible spectrum of the cobalt(III) 
deuterophorphyrins at acidic pH, λmax = 416 nm. 
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The product was then purified by preparative RP-HPLC (Fig.72), and the 
ESI-MS IT- analysis of the pure prodcut confirmed the identity of the 
desired compound (expected molecular weight 4890.3 amu ). 
 
Fig. 72 HPLC chromatogram of Co(III)- Mimochrome VII   
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7.2. CD and UV-Vis spectroscopy 
CD spectra were obtained at 298 K on a Jasco J-715 dichrograph. Data were 
collected from 260 to 190 nm at 0.2 nm intervals with a 20 nm min
-1
 scan 
speed, at 1 nm bandwidth and at 16 s response. Cuvette path length of 0.1 cm 
was used. Sample concentration was 1*10
-5 
M. CD intensities are reported as 
molar ellipticity per residue (mdeg cm
2
 dmol
-1 
res
-1
). All data are blank 
subtracted. 
UV-Vis spectra were recorded on a Cary Varian 50 Probe UV 
Spectrophotometer. All measurements were performed at room temperature. 
Quartz cuvettes with a path length of 1.0 cm were used for most 
measurements. Wavelength scans were performed from 200 nm to 700 nm, 
with a 300 nm min
-1
 scan speed. All data are blank subtracted.  
pH titration was performed in aqueous solution, using TFA solutions (0.1 M 
and 1M) trifluoroacetic acid to lower pH. The concentration of Mimochrome 
VII was 1.0 * 10-5M. Dilution was less than 3 % and considered in the final 
data. The pKa’s were determined by monitoring the changes in absorbance at 
388 nm as a function of proton concentration.  
 
The data were analyzed assuming the following  equilibria: 
 
The equilibrium constants can be expressed as: 
][
][][
;
][
][][ 0
22
2
1 





AH
HA
aKAH
HAH
aK
           (eq.2) 
Each of them can be expressed in dependence of [A0]. The total absorbance 
and the total concentration can be expressed as sum of the all species: 
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21
2
0
2
2
0
100
][][][][
][
aKaK
HA
aK
HA
AtotAbs 



     (eq.3) 
][][][][ 2
20
 AHAHAtot
                                                   (eq.4)  
 
Next, [A0] is isolated from eq. 4, and substituted in eq. 3, obtaining: 
212
21
2
2
10
2][][
1
2][][
][
aKaK
H
aK
H
aKaK
H
aK
H
tot
totAbs























   (eq.5)  
Multiplying the numerator and the denominator of the right-hand side,  by 
   [ ] tot ·  Ka1 · Ka2, eq. 2 can be written as: 
 
2
121
2
211210
][][
][][



HHaKaKaK
HHaKaKaK
tot

                             (eq.6) 
where ε0, ε1, ε2  are the molar extinction coefficients of the different species. 
Eq.6 was used to fit the observed ε388nm as function of [H
+
]. 
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7.3. NMR spectroscopy 
7.3.1. NMR data collection  
Samples for NMR spectroscopy were prepared using by dissolving weighted 
amounts of Co(III)-Mimochrome VII symmetric in H2O/ TFE 50/50 (v/v) 
(pH = 4.6) (V = 0.500 ml) for a final concentration of 5.3 * 10
-4 
mM. 
All NMR spectra were acquired at at 298 K on a Bruker Avance 600 
spectrometer equipped with a triple resonance cryo-probe. Suppression of 
the water signal was accomplished by excitation sculpting sequence. Two 
dimensional NOESY, TOCSY and DQF-COSY spectra were acquired at 
very high digital resolution, using standard pulse sequences. NOESY spectra 
were acquired using mixing time between 200 and 350 ms. TOCSY 
experiment were performed with spin lock applied for 60 or 70 ms. 
 
7.3.2. NMR data analysis 
 Spectra were processed using Bruker TOPSPIN software and analyzed with 
the CARA program. The 
1
H chemical shifts (in ppm) for c.1 and c.2 are 
reported in table 12 and 13, respectively. 
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Table 12: Co(III)-Mimochrome VII compound 1 assignment. 
Peptide chain linked to propionate at position 2 
Aa H-N H- H- H- H-δ others 
Thr1 7.91 4.37 4.27 1.20   
Asn2 8.35 4.69 2.65  
6.62 
7.36 
 
Asp3 8.17 4.57 
2.645 
2.618 
   
Trp4 7.81 4.40 3.04   
Ηδ1 7.00 
Ηε1 9.67 
Hε3 7.29 
Hζ3  6.76 
Hζ2  9.69 
Hη    6.81 
Asp5 7.37 4.48 2.29    
Pro6  3.96 2.13 1.85 
3.61 
3.43 
 
Thr7 7.57 3.72 3.85 0.98   
His8 7.12 2.31 
1.25 
1.08 
  
Ηδ1   9.11 
Ηδ2  -0.382 
Ηε1   0.024 
Gln9 7.23 3.25 1.76 2.10  
Ηε12     7.31 
6.28 
Glu10 7.38 3.87 
1.97 
1.92 
2.30   
Lys11 7.15 3.79 0.14 1.17 1.42 
Ηε,ε’ 2.78 
2.18 
Hζ 7.88 
Leu12 7.22 4.28 
1.50 
1.07 
1.50 
1.78 
1.30 
 
Glu13 8.16 3.89 2.1 
2.50 
2.27 
  
Lys14 8.10 4.06 2.01 1.53 1.73 Hε,ε’ 3.02 
Arg15 8.00 4.39 
2.48 
2.36 
2.01 
3.58 
3.46 
Hε 7.55 
Leu16 8.47 4.39 2.00 1.66 
1.06 
1.03 
 
Lys17 8.09 4.31 1.97 1.52 1.65 Hε,ε’ 3.00 
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Peptide chain linked to propionate at position 18 
Aa H-N H- H- H- H-δ others 
Thr1 7.91 4.37 4.27 1.20   
Asn2 8.35 4.69 2.65  
6.62 
7.36 
 
Asp3 8.17 4.57 
2.64 
2.62 
8.17 4.57  
Trp4 7.81 4.40 3.04   
Ηδ1 7.00 
Ηε1 6.69 
Hε3 7.29 
Hζ3 6.76 
Hζ2 9.96 
Hη 6.85 
Asp5 7.34 4.51 2.27    
Pro6  3.98 2.13 1.85 
3.61 
3.43 
 
Thr7 7.55 3.72 3.83 0.97   
His8 7.08 2.37 
1.27 
1.09 
  
Ηδ1 9.17 
Ηδ2 -0.40 
Ηε1  0.092 
Gln9 7.28 3.31 1.78 2.12  
Ηε12 7.32 
6.31 
Glu10 7.46 3.88 
1.98 
1.91 
2.30 
2.22 
  
Lys11 7.20 3.79 0.16 1.14 1.42 
Ηε,ε’ 2.68 
2.18 
Hζ 7.77 
Leu12 7.29 4.17 
1.48 
1.24 
1.38 
0.75 
0.55 
 
Glu13 8.10 3.90 2.09 
2.49 
2.27 
  
Lys14 8.05 4.06 2.00 1.53 1.71 Hε,ε’ 3.00 
Arg15 7.92 4.37 
2.36 
2.29 
2.01 
3.58 
3.46 
Ηε 7.55 
Leu16 8.39 4.36 1.95 1.64 
1.03 
1.02 
 
Lys17 8.04 4.31 1.96 1.52 1.65  
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Deuteroporphyrin IX  assignments. 
2 -α,α’CH2 4.86, 4.26 8H 9.42 
18-α,α’CH2 4.87, 4.27 10 H 10.48 
2 -β,β’CH2 3.73, 3.36 12CH3 3.76 
18-β,β’CH2 3.68, 3.33 13 H 9.35 
3CH3 3.73 15 H 10.34 
5H 10.5 17CH3 3.68 
7 CH3 3.78 20 H 10.41 
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Table 13:  Co(III)-Mimochrome VII compound  2 assignment. 
Peptide chain linked to propionate at position 2 
Aa H-N H- H- H- H-δ others 
Thr1       
Asn2 8.38 4.74 2.69  
6.66 
7.43 
 
Asp3 8.23 4.63 2.72    
Trp4 7.79 4.3 
2.93 
2.88 
  
Ηδ1 6.93 
Ηε1 9.81 
Hε3 7.08 
Hζ3 7.08 
Hζ2 7.21 
Hη 6.49 
Asp5 7.03 4.5 2.39    
Pro6  3.91 2.17 1.74 
3.56 
3.47 
 
Thr7 7.45 3.61 3.55 0.78   
His8 6.88 2.26 
1.08 
0.71 
  
Ηδ1 9.44 
Ηδ2 -0.507 
Ηε1  0.155 
Gln9 7.33 3.54 1.87 2.19  
Ηε,ε’ 7.40 
    6.40 
Glu10 7.65 3.91 
1.95 
1.91 
2.32   
Lys11 7.27 3.81 1.05 -0.15 1.04 
Ηε, ε’ 3.13 
        2.06 
Hζ  6.83 
Leu12 7.61 4.23 
1.60 
 
1.74 
1.56 
1.02 
0.83 
 
Glu13 8.18 3.91 2.11 
2.54 
2.30 
  
Lys14 8.00 4.06 1.95 1.51 1.72  
Arg15 7.94 4.31 
2.28 
2.24 
1.96 
3.49 
3.39 
Ηε 7.49 
Leu16 8.39      
Lys17       
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Peptide chain linked to propionate at position 18 
Aa H-N H- H- H- H-δ others 
Thr1       
Asn2 8.35 4.69 2.65  
6.65 
7.40 
 
Asp3 8.19 4.7 2.65    
Trp4 7.75 4.3 
2.90 
2.81 
  
Ηδ1 6.94 
Ηε1 9.73 
Hε3 7.17 
Hζ3 7.14 
Hζ2 7.28 
Hη 6.51 
Asp5 7.18 4.48 2.4    
Pro6  3.91 2.17 1.74 
3.56 
3.47 
 
Thr7 7.39 3.59 3.44 0.73   
His8 6.84 2.34 
1.16 
0.82 
 
  
Ηδ1 9.65 
Ηδ2 -0.504 
Ηε1  0.20 
Gln9 7.43 3.49 1.86 2.16  
Ηε21 7.33 
Ηε22 6.41 
Glu10 7.75 3.90 
1.95 
1.87 
2.34   
Lys11 7.28 3.79 1.09 0.14 1.10 
Ηε,ε’ 3.17 
        2.14 
Hζ 9.96 
Leu12 7.64 4.13 
1.59 
1.56 
1.44 
0,93 
 0.56 
 
Glu13 8.16 3.89 2.13    
Lys14 7.98 4.03 1.97 1.52 1.70  
Arg15 7.86 4.28 
2.20 
2.16 
1.92 
3.45 
3.35 
Ηε 7.46 
Leu16 8.33 4.31 1.90 1.61 0.97  
Lys17 7.99 4.28 1.93 1.50 1.64  
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Deuteroporphyrin  IX assignments. 
2 -α,α’CH2 4.79, 4.37 8H 9.45 
18-α,α’CH2 4.77, 4.33 10 H 10.59 
2 -β,β’CH2 3.33, 3.26 12CH3 3.82 
18-β,β’CH2 3.33, 3.26 13 H 9.31 
3CH3 3.68 15 H 10.34 
5H 10.50 17CH3 3.62 
7 CH3 3.74 20 H 10.43 
 
Intensities of dipolar connectivities in the two-dimensional NOESY 
spectrum, obtained using a 200 ms mixing time, were measured using the 
integration subroutine of the CARA program. Peak volumes were converted 
into upper limit of inter-atomic distances, to be used as input for structural 
calculation. 
 A total of 777 NOESY cross peaks was assigned, integrated and 
transformed in upper distance limits with the program CALIBA,
158
 for peak 
a and peak b, respectively. Of these NOE upper distance limits, 177 were 
removed, because they do not effectively restrict the conformation. In 
conclusion, we obtain two set of 554 upper distance limit restraints that were 
used as input for structural calculation. As for Co(III)-Mimochrome VI-
2U1L in order to perform the simulated annealing, two non standard residue 
were added to the CYANA standard library and additional restraints were 
added to simulate the histidine coordination, and the amide bond formation 
between the lysine side chain and the deuterporphyrin. The quality of the 
obtained structures was evaluated in terms of deviations from ideal lengths 
and bond angles through a Ramachandran plot obtained using the program 
PROCHECK-NMR. 
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8. Fe(III)-Mimochrome IV 
8.1.  NMR data collection 
The NMR analysis of the paramagnetic Fe(III)-Mimochrome IV complex 
was performed in phosphate buffer (10 mM, pH 6.5)/TFE/DMSO solution 
(60/20/20, v/v/v) at 298 K. NMR samples were prepared by dissolving 
weighted amounts of the compound in the solvent system (V = 0.600 ml) for 
a final concentration of 0.6 mM. Proton 1D and 2D nuclear overhauser 
spectra were collected on a Bruker Avance II 500 MHz spectrometer with a 
5 mm QXI probe at “Centro de Ressonância Magnética António Xavier” 
(CERMAX), hosted at the Instituto de Tecnologia Química e Biológica 
(ITQB), Oeiras, Portugal.  
Proton 
1
H nmr spectra were acquired with a spectral width of 30 kHz, 
collecting 4 K data points. The water signal was suppressed by using a 500 
ms selective pulse.  
WEFT-NOESY spectrum was performed as described in the literature with 
an acquisition time of 50 ms, an interpulse delay (t) of 50 ms and a mixing 
time of 50 ms. The spectral width was of 30 kHz in both dimension. The 
data file generally consisted of 4K and 512 data points in F2 and F1, 
respectively.  
 
8.2. Determination of the axial ligand orientations 
The axial ligand orientations of Fe(III)-Mimochrome IV was determined by 
using the empirical equation proposed by Turner:
 
 
i(ppm) = cos[38.0 sin
2
(i-)-4.1 cos
2
(i +)-15.9]+13.8           (eq.7) (1) 
 
This equation contains two unknown variables, independent from each other, 
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that define the axial ligand orientations: 
 , the acute angle between the two histidine planes, and , the 
average orientation of the His planes, projected on the heme plane, 
with respect to the N21-N23 direction (see figure 3 in the main text).  
 i is the hyperfine shift of the ith methyl, experimentally determine 
for each methyl from NMR spectra. 
 i, is the angle between the metal-ith methyl direction and the metal-
N23 axis; it represents a parameter which is proper to each methyl, 
and can be deduced from the heme geometry. In this paper, we used 
the i values proposed by Turner (table 14). 
The equation (7) was implemented in Microsoft office excel and, for each 
methyl, the experimental δ  value and the θ value, as derived from Turner 
(see table 13), were inserted. The and  values were optimized to obtain 
the best fit to the four experimental δi values (see table 15).  
 
 
 
 
 
 
 
 
 
 
 
 
Table 14 θi for the heme methyl groups 
methyl θi 
7-CH3 108 
-CH3 18 
-CH3 -80 
-CH3 162 
Table 15 1H chemical shifts of the heme methyl groups 
methyl 
δ (ppm) 
experimental 
δ (ppm) 
calculated 
7-CH3 26.1 23.4 
12-CH3 6.7 4.1 
17-CH3 24.5 24.8 
3-CH3 16.9 17.0 
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List of acronyms and abbreviations 
Abs Absorbance 
ABTS  2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) 
Ac Acetyl 
Aib -aminoisobutyric acid 
Ala Alanine 
a.m.u.  Atomic mass unit  
Arg Arginine 
Asn Asparagine 
Asp Aspartic acid 
BOC t-Butoxycarbonyl  
CD Circular Diichroism  
CCP Cytochrome c peroxidase 
Cys Cysteine 
cyt Cytochrome 
DCM Dichloromethane  
DIEA Diisopropylethylamine 
DMF Dimethylformamide 
DMSO Dimethyl sulfoxide 
DP IX Deuteroporphyrin IX  
DQF-COSY  Double Quantum Filter- COrrelation SpectroscopY 
EDT 1,2-ethanedithiol 
ESI -MS Electrospray Ionization- Mass Spectrometry 
far-UV  Far-Ultraviolet 
Fmoc 9-Fluorenylmethoxycarbonyl 
Gln  Glutamine 
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Glu  Glutamic acid 
Gly Glycine 
HATU 
N-[(dimethylamino)-1H-1,2,3-triazolo [4,5-b]pyridin-1-yl-
methylene]-N methylmethanaminium hexafluorophosphate 
N-oxide 
HBTU 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium  
His Histidine  
HOBt  N-hydroxybenzotriazole  
HRP Horseradish Peroxidase 
HSAB Hard and soft acids and bases theory 
ICP-MS Inductively Coupled Plasma - Mass Spectrometry 
Ile Isoleucine 
IT-TOF Ion Trap- Time Of Flight  
kcat Turnover number (in the Michaelis-Menten equation) 
LC Liquid Chromatography  
Leu Leucine 
Lys Lysine 
Met Methionine 
Mmt Methoxytrityl 
MP 8 Microperoxidases 8 
MP 11 Microperoxidases 11 
MS Mass Spectrometry  
NMP N-Methyl-2-pyrrolidone 
NMR Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser SpectroscopY 
Np Heme pyrrole nitrogen  
OtBu Tert-Butoxy 
List of acronyms and abbreviations  
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Pbf 2,2,4,6,7-Pentamethyldihydrobenzofurane-5-sulfonyl 
Pdb Protein Data Bank 
ppm Part per million  
Pro Proline 
RP-HPLC Reverse Phase - High Pressure Liquid Chromatography 
Ser Serine 
SPPS Solid Phase Peptide Synthesis 
Rmsd Root-mean-square deviation 
tBu Tert-Butyl  
TFA Trifluoroacetic acid  
TFE Trifluoroethanol  
Thr Threonine 
TLC Thin Layer Chromatography 
TOCSY TOtal Correlated SpectroscopY 
Trp Tryptophan 
Trt Trityl  
Tyr Tyrosine 
UV-vis Ultra Violet/Visible  
VMD Visual Molecular Dynamics  
Xaa Unspecified Amino Acid 
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